Abramson, D.H., M.R. Melson, L.J. Dunkel, and C.M. Frank. 2001. Third (fourth and fifth) tumours in survivors of retinoblastoma. Ophthalmology 108:1868-1876.

Acquavella, J.F., L.D. Wiggs, R.J. Waxweiler, D.G. Macdonell, G.L. Tietjen, and G.S. Wilkinson. 1985. Mortality among workers at the Pantex weapons facility. Health Phys 48:735-746.

Adams, N., and W.A. Langmead. 1962. An Investigation into the Accuracy Attained in Routine Film-Badge Dosimetry at UKAEA Establishments. Authority Health and Safety Branch Report. Harwell, UK: United Kingdom Atomic Energy Authority.

Aghamohammadi, S.Z., and J.R. Savage. 1991. A BrdU pulse double-labelling method for studying adaptive response. Mutat Res 251:133-141.

Aghamohammadi, S.Z., T. Morris, D.L. Stevens, and J. Thacker. 1992. Rapid screening for deletion mutations in the hprt gene using the polymerase chain reaction: x-ray and alpha-particle mutant spectra. Mutat Res 269:1-7.

Alam, N.A., S. Bevan, M. Churchman, E. Barclay, K. Barker, E.E. Jaeger, H.M. Nelson, E. Healy, A.C. Pembroke, P.S. Friedmann, K. Dalziel, E. Calonje, J. Anderson, P.J. August, M.G. Davies, R. Felix, C.S. Munro, M. Murdoch, J. Rendall, S. Kennedy, I.M. Leigh, D.P. Kelsell, I.P. Tomlinson, and R.S. Houlston. 2001. Localization of a gene (MCUL1) for multiple cutaneous leiomyomata and uterine fibroids to chromosome 1q42.3-q43. Am J Hum Genet 68:1264-1269.

Allan, J.M., C.P. Wild, S. Rollinson, E.V. Willett, A.V. Moorman, G.J. Dovey, P.L. Roddam, E. Roman, R.A. Cartwright, and G.J. Morgan. 2001. Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukemia. Proc Natl Acad Sci USA 98:11592-11597.

Alper, T., C. Mothersill, and C.B. Seymour. 1988. Lethal mutations attributable to misrepair of Q-lesions. Int J Radiat Biol 54:525-530.

Amundson, S.A., and D.J. Chen. 1996. Inverse dose-rate effect for mutation induction by gamma-rays in human lymphoblasts. Int J Radiat Biol 69:555-563.

Amundson, S.A., and H.L. Liber. 1991. A comparison of induced mutations at homologous alleles of the tk locus in human cells. Mutat Res 247: 19-27.

Amundson, S.A., M. Bittner, Y. Chen, J. Trent, P. Meltzer, and A.J. Fornace Jr. 1999a. Fluorescent cDNA microarray hybridization reveals complexity and heterogeneity of cellular genotoxic stress responses. Oncogene 18:3666-3672.

Amundson, S.A., K.T. Do, and A.J. Fornace Jr. 1999b. Induction of stress genes by low doses of gamma rays. Radiat Res 152:225-231.

Anderson, R.M., S.J. Marsden, E.G. Wright, M.A. Kadhim, D.T. Goodhead, and C.S. Griffin. 2000. Complex chromosome aberrations in peripheral blood lymphocytes as a potential biomarker of exposure to high-LET alpha-particles. Int J Radiat Biol 76:31-42.

Anderson, R.N., and P.B. DeTurk. 2002. United States Life Tables, National Vital Statistics Reports, Vol. 50, Number 6, 1-12. Available online at

Andersson, M., G. Engholm, K. Ennow, K.A. Jessen, and H.H. Storm. 1991. Cancer risk among staff at two radiotherapy departments in Denmark. Brit J Radiol 64:455-460.

Angel, J.M., N. Popova, N. Lanko, V.S. Turusov, and J. DiGiovanni. 2000. A locus that influences susceptibility to 1,2-dimethylhydrazine-induced colon tumors maps to the distal end of mouse chromosome 3. Mol Carcinogen 27:47-54.

Antoniou, A.C., P.D. Pharoah, G. McMullan, N.E. Day, M.R. Stratton, J. Peto, B.J. Ponder, and D.F. Easton. 2002. A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes. Brit J Cancer 86:76-83.

Appleby, J.M., J.B. Barber, E. Levine, J.M. Varley, A.M. Taylor, T. Stankovic, J. Heighway, C. Warren, and D. Scott. 1997. Absence of mutations in the ATM gene in breast cancer patients with severe responses to radiotherapy. Brit J Cancer 76:1546-1549.

Arai, T., T. Nakano, K. Fukuhisa, T. Kasamatsu, R. Tsunematsu, K. Masubuchi, K. Yamauchi, T. Hamada, T. Fukuda, H. Noguchi, and M. Murata. 1991. Second cancer after radiation therapy for cancer of the uterine cervix. Cancer 67:394-405.

Armitage, P. 1985. Biometry and medical statistics. Biometrics 41:823-833.

Armitage, P., and R. Doll. 1954. The age distribution of cancer and a multistage theory of carcinogenesis. Brit J Cancer 8:1-12.

Armitage, P., and R. Doll. 1957. A two-stage theory of carcinogenesis in relation to the age distribution of human cancer. Brit J Cancer 11: 161-169.

Armitage, P., and R. Doll. 1961. Stochastic models for carcinogenesis. Pp. 18-38 in Proceedings of the Fourth Berkeley Symposium on Mathematical Statistics and Probability, Vol. 4. Berkeley, CA: University of California Press.

Armour, J.A., M.H. Brinkworth, and A. Kamischke. 1999. Direct analysis by small-pool PCR of MS205 minisatellite mutation rates in sperm after mutagenic therapies. Mutat Res 445:73-80.

Aromaa, A., T.U. Kosunen, P. Knekt, J. Maatela, L. Teppo, O.P. Heinonen, M. Harkonen, and M.K. Hakama. 1996. Circulating anti-Helicobacter pylori immunoglobulin A anitbodies and low serum pepsinogen I level are associated with increased risk of gastric cancer. Am J Epidemiol 144:142-149.

Arseneau, J. C., R. W. Sponzo, D. L. Levin, L. E. Schnipper, H. Bonner, R. C. Young, G. P. Canellos, R. E. Johnson, and V. T. DeVita. 1972. Nonlymphomatous malignant tumors complicating Hodgkin’s disease. Possible association with intensive therapy. N Engl J Med 287: 1119-22.

The National Academies of Sciences, Engineering, and Medicine
500 Fifth St. N.W. | Washington, D.C. 20001

Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 337
References Abramson, D.H., M.R. Melson, L.J. Dunkel, and C.M. Frank. 2001. Third Anderson, R.N., and P.B. DeTurk. 2002. United States Life Tables, Na- (fourth and fifth) tumours in survivors of retinoblastoma. Ophthalmol- tional Vital Statistics Reports, Vol. 50, Number 6, 1-12. Available online ogy 108:1868-1876. at Acquavella, J.F., L.D. Wiggs, R.J. Waxweiler, D.G. Macdonell, G.L. Andersson, M., G. Engholm, K. Ennow, K.A. Jessen, and H.H. Storm. 1991. Tietjen, and G.S. Wilkinson. 1985. Mortality among workers at the Cancer risk among staff at two radiotherapy departments in Denmark. Pantex weapons facility. Health Phys 48:735-746. Brit J Radiol 64:455-460. Adams, N., and W.A. Langmead. 1962. An Investigation into the Accuracy Angel, J.M., N. Popova, N. Lanko, V.S. Turusov, and J. DiGiovanni. 2000. Attained in Routine Film-Badge Dosimetry at UKAEA Establishments. A locus that influences susceptibility to 1,2-dimethylhydrazine-induced Authority Health and Safety Branch Report. Harwell, UK: United King- colon tumors maps to the distal end of mouse chromosome 3. Mol Car- dom Atomic Energy Authority. cinogen 27:47-54. Aghamohammadi, S.Z., and J.R. Savage. 1991. A BrdU pulse double-label- Antoniou, A.C., P.D. Pharoah, G. McMullan, N.E. Day, M.R. Stratton, J. ling method for studying adaptive response. Mutat Res 251:133-141. Peto, B.J. Ponder, and D.F. Easton. 2002. A comprehensive model for Aghamohammadi, S.Z., T. Morris, D.L. Stevens, and J. Thacker. 1992. familial breast cancer incorporating BRCA1, BRCA2 and other genes. Rapid screening for deletion mutations in the hprt gene using the poly- Brit J Cancer 86:76-83. merase chain reaction: x-ray and alpha-particle mutant spectra. Mutat Appleby, J.M., J.B. Barber, E. Levine, J.M. Varley, A.M. Taylor, T. Res 269:1-7. Stankovic, J. Heighway, C. Warren, and D. Scott. 1997. Absence of Alam, N.A., S. Bevan, M. Churchman, E. Barclay, K. Barker, E.E. Jaeger, mutations in the ATM gene in breast cancer patients with severe re- H.M. Nelson, E. Healy, A.C. Pembroke, P.S. Friedmann, K. Dalziel, E. sponses to radiotherapy. Brit J Cancer 76:1546-1549. Calonje, J. Anderson, P.J. August, M.G. Davies, R. Felix, C.S. Munro, Arai, T., T. Nakano, K. Fukuhisa, T. Kasamatsu, R. Tsunematsu, K. M. Murdoch, J. Rendall, S. Kennedy, I.M. Leigh, D.P. Kelsell, I.P. Masubuchi, K. Yamauchi, T. Hamada, T. Fukuda, H. Noguchi, and M. Tomlinson, and R.S. Houlston. 2001. Localization of a gene (MCUL1) Murata. 1991. Second cancer after radiation therapy for cancer of the for multiple cutaneous leiomyomata and uterine fibroids to chromo- uterine cervix. Cancer 67:394-405. some 1q42.3-q43. Am J Hum Genet 68:1264-1269. Armitage, P. 1985. Biometry and medical statistics. Biometrics 41:823- Allan, J.M., C.P. Wild, S. Rollinson, E.V. Willett, A.V. Moorman, G.J. 833. Dovey, P.L. Roddam, E. Roman, R.A. Cartwright, and G.J. Morgan. Armitage, P., and R. Doll. 1954. The age distribution of cancer and a multi- 2001. Polymorphism in glutathione S-transferase P1 is associated with stage theory of carcinogenesis. Brit J Cancer 8:1-12. susceptibility to chemotherapy-induced leukemia. Proc Natl Acad Sci Armitage, P., and R. Doll. 1957. A two-stage theory of carcinogenesis in USA 98:11592-11597. relation to the age distribution of human cancer. Brit J Cancer 11: Alper, T., C. Mothersill, and C.B. Seymour. 1988. Lethal mutations attrib- 161-169. utable to misrepair of Q-lesions. Int J Radiat Biol 54:525-530. Armitage, P., and R. Doll. 1961. Stochastic models for carcinogenesis. Pp. Amundson, S.A., and D.J. Chen. 1996. Inverse dose-rate effect for mutation 18-38 in Proceedings of the Fourth Berkeley Symposium on Mathemati- induction by gamma-rays in human lymphoblasts. Int J Radiat Biol cal Statistics and Probability, Vol. 4. Berkeley, CA: University of Cali- 69:555-563. fornia Press. Amundson, S.A., and H.L. Liber. 1991. A comparison of induced mutations Armour, J.A., M.H. Brinkworth, and A. Kamischke. 1999. Direct analysis at homologous alleles of the tk locus in human cells. Mutat Res 247: by small-pool PCR of MS205 minisatellite mutation rates in sperm after 19-27. mutagenic therapies. Mutat Res 445:73-80. Amundson, S.A., M. Bittner, Y. Chen, J. Trent, P. Meltzer, and A.J. Fornace Aromaa, A., T.U. Kosunen, P. Knekt, J. Maatela, L. Teppo, O.P. Heinonen, Jr. 1999a. Fluorescent cDNA microarray hybridization reveals com- M. Harkonen, and M.K. Hakama. 1996. Circulating anti-Helicobacter plexity and heterogeneity of cellular genotoxic stress responses. pylori immunoglobulin A anitbodies and low serum pepsinogen I level Oncogene 18:3666-3672. are associated with increased risk of gastric cancer. Am J Epidemiol Amundson, S.A., K.T. Do, and A.J. Fornace Jr. 1999b. Induction of stress 144:142-149. genes by low doses of gamma rays. Radiat Res 152:225-231. Arseneau, J. C., R. W. Sponzo, D. L. Levin, L. E. Schnipper, H. Bonner, R. Anderson, R.M., S.J. Marsden, E.G. Wright, M.A. Kadhim, D.T. Goodhead, C. Young, G. P. Canellos, R. E. Johnson, and V. T. DeVita. 1972. and C.S. Griffin. 2000. Complex chromosome aberrations in peripheral Nonlymphomatous malignant tumors complicating Hodgkin’s disease. blood lymphocytes as a potential biomarker of exposure to high-LET Possible association with intensive therapy. N Engl J Med 287: 1119-22. alpha-particles. Int J Radiat Biol 76:31-42. 337

OCR for page 337
338 REFERENCES Artalejo, F.R., S.C. Lara, B. de Andres Manzano, M.G. Ferruelo, L.I. Mar- Bailey, S.M., M.A. Brenneman, J. Halbrook, J.A. Nickoloff, R.L. Ullrich, tin, and J.R. Calero. 1997. Occupational exposure to ionising radiation and E.H. Goodwin. 2004a. The kinase activity of DNA-PK is required and mortality among workers of the former Spanish Nuclear Energy to protect mammalian telomeres. DNA Repair (Amst) 3:225-233. Board. Occup Environ Med 54:202-208. Bailey, S.M., M.N. Cornforth, R.L. Ullrich, and E.H. Goodwin. 2004b. Artandi, S.E., S. Chang, S.L. Lee, S. Alson, G.J. Gottlieb, L. Chin, and R.A. Dysfunctional mammalian telomeres join with DNA double-strand DePinho. 2000. Telomere dysfunction promotes non-reciprocal translo- breaks. DNA Repair (Amst) 3:349-357. cations and epithelial cancers in mice. Nature 406:641-645. Baird, P.A., T.W. Anderson, H.B. Newcombe, and R.B. Lowry. 1988. Ge- Ashizawa, K., Y. Shibata, S. Yamashita, H. Namba, M. Hoshi, N. netic disorders in children and young adults: a population study. Am J Yokoyama, M. Izumi, and S. Nagataki. 1997. Prevalence of goiter and Hum Genet 42:677-693. urinary iodine excretion levels in children around Chernobyl. J Clin Baker, T.G. 1971. Comparative aspects of the effects of radiation during Endocr Metab 82:3430-3433. oogenesis. Mutat Res 11:9-22. Ashmore, J.P., D. Krewski, J.M. Zielinski, H. Jiang, R. Semenciw, and P.R. Bakkenist, C.J., and M.B. Kastan. 2003. DNA damage activates ATM Band. 1998. First analysis of mortality and occupational radiation expo- through intermolecular autophosphorylation and dimer dissociation. sure based on the National Dose Registry of Canada. Am J Epidemiol Nature 421:499-506. 148:564-574. Balmain, A., and H. Nagase. 1998. Cancer resistance genes in mice: models Astakhova, L.N., L.R. Anspaugh, G.W. Beebe, A. Bouville, V.V. for the study of tumour modifiers. Trends Genet 14:139-144. Drozdovitch, V. Garber, Y.I. Gavrilin, V.T. Khrouch, A.V. Balmain, A., J. Gray, and B. Ponder. 2003. The genetics and genomics of Kuvshinnikov, Y.N. Kuzmenkov, V.P. Minenko, K.V. Moschik, A.S. cancer. Nat Genet 33(Suppl):238-244. Nalivko, J. Robbins, E.V. Shemiakina, S. Shinkarev, S.I. Tochitskaya, Barber, R., M. Plumb, A.G. Smith, C.E. Cesar, E. Boulton, A.J. Jeffreys, and M.A. Waclawiw. 1998. Chernobyl-related thyroid cancer in chil- and Y.E. Dubrova. 2000. No correlation between germline mutation at dren of Belarus: a case-control study. Radiat Res 150:349-356. repeat DNA and meiotic crossover in male mice exposed to x-rays or Aszterbaum, M., J. Epstein, A. Oro, V. Douglas, P.E. LeBoit, M.P. Scott, cisplatin. Mutat Res 457:79-91. and E.H. Epstein Jr. 1999. Ultraviolet and ionizing radiation enhance Barber, R., M.A. Plumb, E. Boulton, I. Roux, and Y.E. Dubrova. 2002. the growth of BCCs and trichoblastomas in patched heterozygous Elevated mutation rates in the germ line of first- and second-generation knockout mice. Nat Med 5:1285-1291. offspring of irradiated male mice. Proc Natl Acad Sci USA 99:6877- Atkinson, W.D., D.V. Law, K.J. Bromley, and H.M. Inskip. 2004. Mortal- 6882. ity of employees of the United Kingdom Atomic Energy Authority, Baria, K., C. Warren, S.A. Roberts, C.M. West, and D. Scott. 2001. Chro- 1946-97. Occup Environ Med 61:577-585. mosomal radiosensitivity as a marker of predisposition to common can- Austin, D.F., and P. Reynolds. 1997. Investigation of an excess of mela- cers? Brit J Cancer 84:892-896. noma among employees of the Lawrence Livermore National Labora- Barlow, C., S. Hirotsune, R. Paylor, M. Liyanage, M. Eckhaus, F. Collins, tory. Am J Epidemiol 145:524-531. Y. Shiloh, J.N. Crawley, T. Reid, D. Tagle, and A. Wynshaw-Boris. Auvinen, A., M. Hakama, H. Arvela, T. Hakulinen, T. Rahola, M. Suomela, 1996. Atm-deficient mice: a paradigm of ataxia-telangiectasia. Cell B. Soderman, and T. Rytomaa. 1994. Fallout from Chernobyl and inci- 86:159-171. dence of childhood leukaemia in Finland, 1976-92. Brit Med J 309: Barlow, C., P.A. Dennery, M.K. Shigenaga, M.A. Smith, J.D. Morrow, L.J. 151-154. Roberts 2nd, A. Wynshaw-Boris, and R.L. Levine. 1999. Loss of the Auvinen, A., E. Pukkala, H. Hyvonen, M. Hakama, and T. Rytomaa. 2002. ataxia-telangiectasia gene product causes oxidative damage in target Cancer incidence among Finnish nuclear reactor workers. J Occ Env organs. Proc Natl Acad Sci USA 96:9915-9919. Med 44:634-638. Barquinero, J.F., L. Barrios, M.R. Caballin, R. Miro, M. Ribas, A. Subias, Azzam, E.I., G.P. Raaphorst, and R.E.J. Mitchel. 1994. Radiation-induced and J. Egozcue. 1995. Occupational exposure to radiation induces an adaptive response for protection against micronucleus formation and adaptive response in human lymphocytes. Int J Radiat Biol 67:187-191. neoplastic transformation in C3H 10T1/2 mouse embryo cells. Radiat Bartsch, H., M. Hollstein, R. Mustonen, J. Schmidt, A. Spiethoff, H. Wesch, Res 138:S28-S31. T. Wiethege, and K.M. Muller. 1995. Screening for putative radon-spe- Azzam, E.I., S.M. de Toledo, G.P. Raaphorst, and R.E.J. Mitchel. 1996. cific p53 mutation hotspot in German uranium miners. Lancet 346:121. Low-dose ionizing radiation decreases the frequency of neoplastic trans- Basco, V.E., A.J. Coldman, J.M. Elwood, and M.E. Young. 1985. Radia- formation to a level below the spontaneous rate in C3H 10T1/2 cells. tion dose and second breast cancer. Brit J Cancer 52:319-325. Radiat Res 146:369-373. Bauchinger, M., E. Schmid, S. Streng, and J. Dresp. 1983. Quantitative Azzam, E.I., S.M. de Toledo, T. Gooding, and J.B. Little. 1998. Intercellu- analysis of the chromosome damage at first division of human lympho- lar communication is involved in the bystander regulation of gene ex- cytes after 60CO gamma-irradiation. Radiat Environ Bioph 22:225-229. pression in human cells exposed to very low fluences of alpha particles. Baumann, P., and S.C. West. 1998. DNA end-joining catalyzed by human Radiat Res 150:497-504. cell-free extracts. Proc Natl Acad Sci USA 95:14066-14070. Azzam, E.I., S.M. de Toledo, D.R. Spitz, and J.B. Little. 2002. Oxidative Baverstock, K., B. Egloff, A. Pinchera, C. Ruchti, and D. Williams. 1992. metabolism modulates signal transduction and micronucleus formation Thyroid cancer after Chernobyl. Nature 359:21-22. in bystander cells from alpha-particle-irradiated normal human fibro- Beauchesne, P.D., S. Bertrand, R. Branche, S.P. Linke, R. Revel, J.F. Dore, blast cultures. Cancer Res 62:5436-5442. and R.M. Pedeux. 2003. Human malignant glioma cell lines are sensi- Bacchetti, S. 1996. Telomere maintenance in tumour cells. Cancer Surv tive to low radiation doses. Int J Cancer 105:33-40. 28:197-216. Bebeshko, V.G., E.M. Bruslova, V.I. Klimenko, and others. 1997. Leuke- Backlund, M.G., S.L. Trasti, D.C. Backlund, V.L. Cressman, V. Godfrey, mias and lymphomas in Ukraine population exposed to chronic low and B.H. Koller. 2001. Impact of ionizing radiation and genetic back- dose irradiation. Pp. 337-338 in Low Doses of Ionizing Radiation: Bio- ground on mammary tumorigenesis in p53-deficient mice. Cancer Res logical Effects and Regulatory Control. Contributed papers. Interna- 61:6577-6582. tional Conference held in Seville, Spain. IAEA-TECDOC-976. Bacq, Z.M., and P. Alexander. 1961. Fundamentals of Radiobiology. New Beckman, K.B., and B.N. Ames. 1997. Oxidative decay of DNA. J Biol York: Pergamon Press. Chem 272:19633-19636. Bailey, S.M., J. Meyne, D.J. Chen, A. Kurimasa, G.C. Li, B.E. Lehnert, and Bedford, J.S., and W.C. Dewey. 2002. Radiation Research Society. 1952- E.H. Goodwin. 1999. DNA double-strand break repair proteins are re- 2002. Historical and current highlights in radiation biology: has any- quired to cap the ends of mammalian chromosomes. Proc Natl Acad Sci thing important been learned by irradiating cells? Radiat Res 158:251- USA 96:14899. 291.

OCR for page 337
REFERENCES 339 Bell, G.I., S. Horita, and J.H. Karam. 1984. A polymoprhic locus near the Bithell, J.F. 1990. An application of density estimation to geographical epi- human insulin gene is associated with insulin-dependent diabetes melli- demiology. Stat Med 9:691-701. tus. Diabetes 31:176-183. Bithell, J.F. 1993. Statistical issues in assessing the evidence associating Belyaev, I.Y., and M. Harms-Ringdahl. 1996. Effects of gamma rays in the obstetric irradiation and childhood malignancy. Pp. 53-60 in Neue 0.5-50-cGy range on the conformation of chromatin in mammalian cells. Bewertung des Strahlenriskos: Niedrigdosis-Strahlung und Gesundheit, Radiat Res 145:687-693. E. Lengfelder and H. Wendhausen, eds. Munich: MMV Medizin Verlag. Belyakov, O.V., A.M. Malcolmson, M. Folkard, K.M. Prise, and B.D. Bithell, J.F., and A.M. Stewart. 1975. Pre-natal irradiation and childhood Michael. 2001. Direct evidence for a bystander effect of ionizing radia- malignancy: a review of British data from the Oxford Survey. Brit J tion in primary human fibroblasts. Brit J Cancer 84:674-679. Cancer 31:271-287. Bender, M.A., H.G. Griggs, and J.S. Bedford. 1974. Mechanisms of chro- Bithell, J.F., S.J. Dutton, G.J. Draper, and N.M. Neary. 1994. Distribution mosomal aberration production. 3. Chemicals and ionizing radiation. of childhood leukaemias and non-Hodgkin’s lymphomas near nuclear Mutat Res 23:197-212. installations in England and Wales. Brit Med J 309:501-505. Bennett, R.A., D.M. Wilson 3rd, D. Wong, and B. Demple. 1997. Interac- Black, R.J., J.D. Urquhart, S.W. Kendrick, K.J. Bunch, J. Warner, and D.A. tion of human apurinic endonuclease and DNA polymerase beta in the Jones. 1992. Incidence of leukaemia and other cancers in birth and base excision repair pathway. Proc Natl Acad Sci USA 94:7166-7169. schools cohorts in the Dounreay area. Brit Med J 304:1401-1405. Bennett, S.T., A.M. Lucassen, S.C. Gough, E.E. Powell, D.E. Undlien, L.E. Black, R.J., L. Sharp, E.F. Harkness, and P.A. McKinney. 1994a. Leu- Pritchard, M.E. Merriman, Y. Kawaguchi, M.J. Dronsfield, F. Pociot, kaemia and non-Hodgkin’s lymphoma: incidence in children and young and 1 other. 1995. Susceptibility to human type 1 diabetes at IDDM2 is adults resident in the Dounreay area of Caithness, Scotland in 1968-91. determined by tandem repeat variation at the insulin gene minisatellite J Epidemiol Commun H 48:232-236. locus. Nat Genet 9:284-292. Black R.J., L. Sharp, A.R. Finlayson, E.F. Harkness. 1994b. Cancer inci- Bennett, W.P., M.C. Alavanja, B. Blomeke, K.H. Vahakangas, K. Castren, dence in a population potentially exposed to radium-226 at Dalgety Bay, J.A. Welsh, E.D. Bowman, M.A. Khan, D.B. Flieder, and C.C. Harris. Scotland. Brit J Cancer 69:140-143. 1999. Environmental tobacco smoke, genetic susceptibility, and risk of Blackburn, E.H. 2000. Telomere states and cell fates. Nature 408:53-56. lung cancer in never-smoking women. J Natl Cancer Inst 91:2009-2014. Blaisdell, J.O., and S.S. Wallace. 2001. Abortive base-excision repair of Beral, V., H. Inskip, P. Fraser, M. Booth, D. Coleman, and G. Rose. 1985. radiation-induced clustered DNA lesions in Escherichia coli. Proc Natl Mortality of employees of the United Kingdom Atomic Energy Author- Acad Sci USA 98:7426-7430. ity, 1946-1979. Brit Med J (Clin Res Ed) 291:440-447. Blake, J.A., J.T. Eppig, J.E. Richardson, and M.T. Davisson. 2000. The Beral, V., P. Fraser, L. Carpenter, M. Booth, A. Brown, and G. Rose. 1988. Mouse Genome Database (MGD): expanding genetic and genomic re- Mortality of employees of the Atomic Weapons Establishment, 1951- sources for the laboratory mouse. The Mouse Genome Database Group. 1982. Brit Med J 297:757-770. Nucleic Acids Res 28:108-111. Berrington, A., S.C. Darby, H.A. Weiss, and R. Doll. 2001. 100 years of Blattner, C., A. Knebel, A. Radler-Pohl, C. Sachsenmaier, P. Herrlich, and observation on British radiologists: mortality from cancer and other H.J. Rahmsdorf. 1994. DNA damaging agents and growth factors in- causes 1897-1997. Brit J Radiol 74:507-519. duce changes in the program of expressed gene products through com- Bertoni, L., C. Attolini, L. Tessera, E. Mucciolo, and E. Giulotto. 1994. mon routes. Environ Mol Mutagen 24:3-10. Telomeric and nontelomeric (TTAGGG) n sequences in gene amplifi- Blattner, C., E. Tobiasch, M. Litfen, H.J. Rahmsdorf, and P. Herrlich. 1999. cation and chromosome stability. Genomics 24:53-62. DNA damage induced p53 stabilization: no indication for an involve- Bettega, D., P. Calzolari, A. Ottolenghi, E. Rimoldi, and L. Tallone ment of p53 phosphorylation. Oncogene 18:1723-1732. Lombardi. 1989. Cell density dependence of transformation frequen- Blettner, M., and H. Zeeb. 1999. Epidemiological studies among pilots and cies in C3H10T1/2 cells exposed to x-rays. Int J Radiat Biol 56:989- cabin crew. Radiat Prot Dosimet 86:269-273. 998. Blettner, M., B. Grosche, and H. Zeeb. 1998. Occupational cancer risk in Billen, D. 1990. Spontaneous DNA damage and its significance for the pilots and flight attendants: current epidemiological knowledge. Radiat “negligible dose” controversy in radiation protection. Radiat Res Environ Bioph 37:75-80. 124:242-245. Bleuer, J.P., Y.I. Averkin, and T. Abelin. 1997. Chernobyl-related thyroid Binks, K., D.I. Thomas, and D. McElvenny. 1989. Mortality of workers at cancer: what evidence for role of short-lived iodines. Environ Health Chapelcross plant of British Nuclear Fuels Limited. Cancer 67:615-624. Persp 105:1483-1486. Birdwell, S.H., S.L. Hancock, A. Verghese, R.S. Cox, and R.T. Hoppe. BNL (Brookhaven National Laboratory). Conard, R.A., D.E. Peglia, P.R. 1997. Gastrointestinal cancer after treatment of Hodgkin’s disease. Int J Larson, and others. 1980. Review of Medical Findings in a Marshallese Radiat Oncol 37:67-73. Population Twenty-Six Years after Accidental Exposure to Radioactive Birrell, G.W., G. Giaever, A.M. Chu, R.W. Davis, and J.M. Brown. 2001. A Fallout. BNL 51261. Upton, NY: Brookhaven National Laboratory. genome-wide screen in Saccharomyces cerevisiae for genes affecting Boice, J.D., Jr., and R.W. Miller. 1992. Risk of breast cancer in ataxia- UV radiation sensitivity. Proc Natl Acad Sci USA 98:12608-12613. telangiectasia. New Engl J Med 326:1357-1358; discussion 1360-1361. Birrell, G.W., J.A. Brown, H.I. Wu, G. Giaever, A.M. Chu, R.W. Davis, Boice, J.D., Jr., and R.W. Miller. 1999. Childhood and adult cancer after and J.M. Brown. 2002. Transcriptional response of Saccharomyces intrauterine exposure to ionizing radiation. Teratology 59:227-233. cerevisiae to DNA-damaging agents does not identify the genes that Boice, J.D., Jr., M. Rosenstein, and E.D. Trout. 1978. Estimation of breast protect against these agents. Proc Natl Acad Sci USA 99:8778-8783. doses and breast cancer risk associated with repeated fluoroscopic chest Bishayee, A., D.V. Rao, and R.W. Howell. 1999. Evidence for pronounced examinations of women with tuberculosis. Radiat Res 73:373-390. bystander effects caused by nonuniform distributions of radioactivity Boice, J.D., Jr., N.E. Day, A. Andersen, L.A. Brinton, R. Brown, N.W. using a novel three-dimesional tissue culture model. Radiat Res 152: Choi, E.A. Clarke, M.P. Coleman, R.E. Curtis, J.T. Flannery, M. 88-97. Hakama, T. Hakulinen, G.R. Howe, O.M. Jensen, R.A. Kleinerman, D. Bishop, D.T. 1990. Multifactorial inheritance. Pp. 165-174 in Principles Magnin, K. Magnus, K. Mäkelä, B. Malker, A.B. Miller, N. Nelson, and Practice of Medical Genetics. New York: Churchill Livingstone. C.C. Patterson, F. Pettersson, V. Pompe-Kirn, M. Primic-Zakelj, P. Bishop, D.T., and J. Hopper. 1997. AT-tributable risks? Nat Genet 15:226. Prior, B. Ravnihar, R.G. Skeet, J.E. Skjerven, P.G. Smith, M. Sok, R.F. Bishop, J.M. 1991. Molecular themes in oncogenesis. Cell 64:235-248. Spengler, H.H. Storm, M. Stovall, G.W.O. Tomkins, and C. Wall. 1985. Bithell, J.F. 1989. Epidemiological studies of children irradiated in utero. Second cancers following radiation treatment for cervical cancer. An Pp. 77-87 in Low Dose Radiation: Biological Bases of Risk Assess- international collaboration among cancer registries. J Natl Cancer Inst ment, K.F. Baverstock and J.W. Stather, eds. London: Taylor & Francis. 74:955-975.

OCR for page 337
340 REFERENCES Boice, J.D., Jr., M. Blettner, R.A. Kleinerman, M. Stovall, W.C. Moloney, Bonser, G., and J. Jull. 1977. Tumors of the ovary. Pp. 129-184 in The G. Engholm, D.F. Austin, A. Bosch, D.L. Cookfair, E.T. Krementz, Ovary, L. Zuckerman and B. Weir, eds. New York: Academic Press. H.B. Latourette, L.J. Peters, M.D. Schulz, M. Lundell, F. Pettersson, Boothman, D.A., M. Meyers, N. Fukunaga, and S.W. Lee. 1993. Isolation H.H. Storm, J. Bell, M.P. Coleman, P. Fraser, M. Palmer, P. Prior, N.W. of x-ray inducible transcripts from radioresistant human melanoma cells. Choi, T.G. Hilsop, M. Kock, D. Robb, D. Robson, R.F. Spengler, M. Proc Natl Acad Sci USA 90:7200-7204. von Fournier, R. Frischkorn, H. Lochmuller, V. Pompe-Kirn, A. Borek, C., E.J. Hall, and M. Zaider. 1983. X rays may be twice as potent as Rimpela, M. Kjorstad, H. Pejovic, K. Sigurdsson, P. Pisani, H. Kucera, gamma rays for malignant transformation at low doses. Nature 301: and G.B. Hutchison. 1987. Radiation dose and leukemia risk in patients 156-158. treated for cancer of the cervix. J Natl Cancer Inst 79:1295-1311. Bose, A., and G. Olivieri. 1989. Variability of the adaptive response to Boice, J.D., Jr., G. Engholm, R.A. Kleinerman, M. Blettner, M. Stovall, H. ionizing radiations in humans. Mutat Res 211:13-17. Lisco, W.C. Moloney, D.F. Austin, A. Bosch, D.L. Cookfair, E.T. Boudaiffa, B., P. Cloutier, D. Hunting, M.A. Huels, and L. Sanche. 2000. Krementz, H.B. Latourette, J.A. Merrill, L.J. Peters, M.D. Schulz, H.H. Resonant formation of DNA strand breaks by low-energy (3 to 20 eV) Storm, E. Björkholm, F. Pettersson, C.M.J. Bell, M.P. Coleman, P. electrons. Science 287:1658-1660. Fraser, F.E. Neal, P. Prior, N.W. Choi, T.G. Hislop, M. Koch, N. Bouffler, S.D. 1998. Involvement of telomeric sequences in chromosomal Kreiger, D. Robb, D. Robson, D.H. Thomson, H. Lochmüller, D. von aberrations. Mutat Res 404:199-204. Fournier, R. Frischkorn, K.E. Kjørstad, A. Rimpela, M.H. Pejovic, V. Bouffler, S.D., A. Silver, D. Papworth, J. Coates, and R. Cox. 1991. Murine Pompe Kirn, H. Stankusova, F. Berrino, K. Sigurdsson, G.B. Hutchison, radiation myeloid leukemogenesis: relationship between interstitial te- and B. MacMahon. 1988. Radiation dose and second cancer risk in pa- lomere like sequences and chromosome 2 fragile sites. Gene Chromo- tients treated for cancer of the cervix. Radiat Res 116:3-55. some Canc 6:90-106. Boice, J.D., Jr., M. Blettner, R.A. Kleinerman, G. Engholm, M. Stovall, H. Bouffler, S.D., C.J. Kemp, A. Balmain, and R. Cox. 1995. Spontaneous and Lisco, D.F. Austin, A. Bosch, L. Harlan, E.T. Krementz, and J. ionizing radiation-induced chromosomal abnormalities in p53-deficient Wactawski-Wende. 1989. Radiation dose and breast cancer risk in pa- mice. Cancer Res 55:3883-3889. tients treated for cancer of the cervix. Int J Cancer 44:7-16. Bouffler, S.D., G. Breckon, and R. Cox. 1996. Chromosomal mechanisms Boice, J.D., Jr., M.M. Morin, A.G. Glass, G.D. Friedman, M. Stovall, R.N. in murine radiation acute myeloid leukaemogenesis. Carcinogenesis Hoover, and J.F. Fraumeni. 1991a. Diagnostic x-ray procedures and 17:655-659. risk of leukemia, lymphoma, and multiple myeloma. J Am Med Assoc Bouffler, S.D., E.I. Meijne, D.J. Morris, and D. Papworth. 1997. Chromo- 265:1290-1294. some 2 hypersensitivity and clonal development in murine radiation Boice, J.D., Jr., D. Preston, F.G. Davis, and R.R. Monson. 1991b. Frequent acute myeloid leukaemia. Int J Radiat Biol 72:181-189. chest x-ray fluoroscopy and breast cancer incidence among tuberculosis Bouffler, S.D., J.W. Haines, A.A. Edwards, J.D. Harrison, and R. Cox. patients in Massachusetts. Radiat Res 125:214-222. 2001. Lack of detectable transmissible chromosomal instability after in Boice, J.D., Jr., E.B. Harvey, M. Blettner, M. Stovall, and J.T. Flannery. vivo or in vitro exposure of mouse bone marrow cells to 224Ra alpha 1992. Cancer in the contralateral breast after radiotherapy for breast particles. Radiat Res 155:345-352. cancer. N Engl J Med 326:781-785. Boulton, E., H. Cleary, D. Papworth, and M. Plumb. 2001. Susceptibility to Boice, J.D., Jr., M. Blettner, and A. Auvinen. 2000. Epidemiologic studies radiation-induced leukaemia/lymphoma is genetically separable from of pilots and aircrew. Health Phys 79:576-584. sensitivity to radiation-induced genomic instability. Int J Radiat Biol Bois, P., J.D. Stead, S. Bakshi, J. Williamson, R. Neumann, B. 77:21-29. Moghadaszadeh, and A.J. Jeffreys. 1998a. Isolation and characteriza- Bounacer, A., R. Wicker, B. Caillou, A.F. Cailleux, A. Sarasin, M. tion of mouse minisatellites. Genomics 50:317-330. Schlumberger, and H.G. Suarez. 1997. High prevalence of activating ret Bois, P., J. Williamson, J. Brown, Y.E. Dubrova, and A.J. Jeffreys. 1998b. proto-oncogene rearrangements, in thyroid tumors from patients who A novel unstable mouse VNTR family expanded from SINE B1 ele- had received external radiation. Oncogene 15:1263-1273. ments. Genomics 49:122-128. Boutou, O., A.V. Guizard, R. Slama, D. Pottier, and A. Spira. 2002. Popu- Boivin, J., and G.B. Hutchison. 1982. Coronary heart disease mortality af- lation mixing and leukaemia in young people around the La Hague ter irradiation for Hodgkin’s disease. Cancer 49:2470-2475. nuclear waste reprocessing plant. Brit J Cancer 87:740-745. Boivin, J.F., G.B. Hutchison, M. Lyden, J. Godbold, J. Chorosh, and D. Box, H.C., H.G. Freund, E.E. Budzinski, J.C. Wallace, and A.E. Maccubbin. Schottenfeld. 1984. Second primary cancers following treatment of 1995. Free radical-induced double base lesions. Radiat Res 141:91-94. Hodgkin’s disease. J Natl Cancer Inst 72:233-241. Bradley, W.E., A. Belouchi, and K. Messing. 1988. The aprt heterozygote/ Boland, C.R., J. Sato, H.D. Appelman, R.S. Bresalier, and A.P. Feinberg. hemizygote system for screening mutagenic agents allows detection of 1995. Microallelotyping defines the sequence and tempo of allelic losses large deletions. Mutat Res 199:131-138. at tumour suppressor gene loci during colorectal cancer progression. Branch, P., D.C. Bicknell, A. Rowan, W.F. Bodmer, and P. Karran. 1995. Nat Med 1:902-909. Immune surveillance in colorectal carcinoma. Nat Genet 9:231-232. Bonassi, S., A. Abbondandolo, L. Camurri, L. Dalpra, M. DeFerrari, F. Breckon, G., and R. Cox. 1990. Alpha particle leukaemogenesis. Lancet Degrassi, L. Lamberti, C. Lando, P. Padovani, I. Sbrana, D. Vecchio, 335:656-657. and R. Puntoni. 1995. Are chromosome aberrations in circulating lym- Breckon, G., D. Papworth, and R. Cox. 1991. Murine radiation myeloid phocytes predictive of future cancer onset in humans. Cancer Genet leukemogenesis: a possible role for radiation sensitive sites on chromo- Cytogen 79:133-135. some 2. Gene Chromosome Canc 3:367-375. Bond, V.P., C.B. Meinhold, and H.H. Rossi. 1978. Low-dose RBE and Q Brenner, D.J. 1999. Does fractionation decrease the risk of breast cancer for x-ray compared to gamma-ray radiations. Health Phys 34:433-438. induced by low-LET radiation? Radiat Res 151:225-229. Bondy, M.L., A.P. Kyritsis, J. Gu, M. de Andrade, J. Cunningham, V.A. Brenner, D.J., and C.D. Elliston. 2004. Estimated radiation risks potentially Levin, J.M. Bruner, and Q. Wei. 1996. Mutagen sensitivity and risk of associated with full-body CT screening. Radiology 232:735-738. gliomas: a case-control analysis. Cancer Res 56:1484-1486. Brenner, D.J., and J.F. Ward. 1995. Constraints on energy deposition and Bongarzone, I., M.G. Butti, L. Fugazzola, F. Pacini, A. Pinchera, T.V. target size of multiple-damaged sites associated with DNA DSB. Pp. Vorontsova, E.P. Demidchik, and M.A. Pierotti. 1997. Comparison of 443-446 in Radiat Res 1895-1995, Proceedings of the Tenth Interna- the breakpoint regions of ELE1 and RET genes involved in the genera- tional Congress of Radiation Research, Vol. 2, U. Hagen and others, tion of RET/PTC3 oncogene in sporadic and in radiation-associated eds. papillary thyroid carcinomas. Genomics 42:252-259.

OCR for page 337
REFERENCES 341 Brenner, D.J., P. Hahnfeldt, S.A. Amundson, and R.K. Sachs. 1996. Inter- Burnet, N.G., J. Johansen, I. Turesson, J. Nyman, and J.H. Peacock. 1998. pretation of inverse dose-rate effects for mutagenesis by sparsely ioniz- Describing patients’ normal tissue reactions: concerning the possibility ing radiation. Int J Radiat Biol 70:447-458. of individualising radiotherapy dose prescriptions based on potential Brenner, D.J., C. Elliston, E. Hall, and W. Berdon. 2001. Estimated risks of predictive assays of normal tissue radiosensitivity. Steering Committee radiation-induced fatal cancer from pediatric CT. Am J Roentgenology of the BioMed2 European Union Concerted Action Programme on the 176:289-296. Development of Predictive Tests of Normal Tissue Response to Radia- Brewen, J.G., H.S. Payne, and R.J. Preston. 1976. X-ray-induced chromo- tion Therapy. Int J Cancer 79:606-613. some aberrations in mouse dictyate oocytes. I. Time and dose relation- Burns, F.J., R.E. Albert, I.P. Sinclair, and P. Bennett. 1973. The effect of ships. Mutat Res 35:111-120. fractionation on tumor induction and hair follicle damage in rat skin. Brewer, C., S. Holloway, P. Zawalnyski, A. Schinzel, and D. FitzPatrick. Radiat Res 53:235-240. 1998. A chromosomal deletion map of human malformations. Am J Burns, F.J., R.E. Albert, I.P. Sinclair, and M. Vanderlaan. 1975. The effect Hum Genet 63:1153-1159. of 24-hour fractionation interval on the induction of rat skin tumors by Bridges, B.A. 2001. Radiation and germline mutation at repeat sequences: electron radiation. Radiat Res 62:478-487. are we in the middle of a paradigm shift? Radiat Res 156:631-641. Burns, F.J., R.E. Albert, and S.J. Garte. 1989a. Radiation-induced cancer in Brill, A.G., M. Tomonaga, and R.M. Heyssel. 1962. Leukemia in man fol- rat skin. Carcinog Compr Surv 11:293-319. lowing exposure to ionizing radiation. A summary of the findings in Burns, F.J., R.E. Albert, and S.J. Garte. 1989b. Multiple stages in radiation Hiroshima and Nagasaki, and a comparison with other human experi- carcinogenesis of rat skin. Environ Health Persp 81:67-72. ence. Ann Intern Med 56:590-609. Burns, F.J., R.N. Shore, C. Loomis, and P. Zhao. 2002. PTCH (patched) Broeks, A., N.S. Russell, A.N. Floore, J.H. Urbanus, E.C. Dahler, M.B. and XPA genes in radiation-induced basal cell carcinomas. Pp. 175-178 van’t Veer, A. Hagenbeek, E.M. Noordijk, M.A. Crommelin, F.E. van in Radiation and Homeostasis, T. Sugahara, O. Nikaido, and O. Niwa, Leeuwen, and L.J. van’t Veer. 2000. Increased risk of breast cancer eds. Amsterdam: Elsevier. following irradiation for Hodgkin’s disease is not a result of ATM Byrne, J., S.A. Rasmussen, S.C. Steinhorn, R.R. Connelly, M.H. Myers, germline mutations. Int J Radiat Biol 76:693-698. C.F. Lynch, J. Flannery, D.F. Austin, F.F. Holmes, G.E. Holmes, L.C. Broerse, J.J., and G.B. Gerber. 1982. Neutron carcinogenesis. Commission Strong, and J.J. Mulvihill. 1998. Genetic disease in offspring of long- of the European Communities Directorate-General for Science, Re- term survivors of childhood and adolescent cancer. Am J Hum Genet search and Development Luxembourg. 62:45-52. Broome, E.J., D.L. Brown, and R.E. Mitchel. 1999. Adaptation of human Calabrese, E.J., and L.A. Baldwin. 2000. Radiation hormesis: its historical fibroblasts to radiation alters biases in DNA repair at the chromosomal foundations as a biological hypothesis. Hum Exp Toxicol 19:41-75. level. Int J Radiat Biol 75:681-690. Calabrese, E.J., and L.A. Baldwin. 2003. Toxicology rethinks its central Broome, E.J., D.L. Brown, and R.E. Mitchel. 2002. Dose responses for belief: hormesis demands a reappraisal of the way risks are assessed. adaption to low doses of (60)Co gamma rays and (3)H beta particles in Nature 421:691-692. normal human fibroblasts. Radiat Res 158:181-186. Calabrese, E.J., L.A. Baldwin, and C.D. Holland. 1999. Hormesis: A highly Brown, D.P., and T. Bloom. 1987. Cincinnati, OH: National Institute for generalizable and reproducible phenomenon with important implica- Occupational Safety and Health. National Technical Information Ser- tions for risk assessment. Risk Anal 19:261-281. vices, Springfield, VA. Cao, J., R.L. Wells, and M.M. Elkind. 1992. Enhanced sensitivity to neo- Bryant, P.E. 1984. Enzymatic restriction of mammalian cell DNA using plastic transformation by 137Cs gamma-rays of cells in the G2-/M-phase Pvu II and Bam H1: evidence for the double-strand break origin of chro- age interval. Int J Radiat Biol 62:191-199. mosomal aberrations. Int J Radiat Biol Re 46:57-65. Cao, J., R.L. Wells, and M.M. Elkind. 1993. Neoplastic transformation of Buard, J., A. Bourdet, J. Yardley, Y. Dubrova, and A.J. Jeffreys. 1998. C3H mouse embryo cells, 10T1/2: cell-cycle dependence for 50 kV X- Influences of array size and homogeneity on minisatellite mutation. rays and UV-B light. Int J Radiat Biol 64:83-92. EMBO J 17:3495-3502. Caratero, A., M. Courtade, L. Bonnet, H. Planel, and C. Caratero. 1998. Buard, J., A. Collick, J. Brown, and A.J. Jeffreys. 2000. Somatic versus Effect of a continuous gamma irradiation at a very low dose on the life germline mutation processes at minisatellite CEB1 (D2S90) in humans span of mice. Gerontology 44:272-276. and transgenic mice. Genomics 65:95-103. Cardis, E., and A.E. Okeanov. 1996. What’s feasible and desirable in the Buchholz, T.A., X. Wu, A. Hussain, S.L. Tucker, G.B. Mills, B. Haffty, S. epidemiologic follow-up of Chernobyl. First International Conference Bergh, M. Story, F.B. Geara, and W.A. Brock. 2002. Evidence of hap- of the European Commission, Belarus, the Russian Federation, and the lotype insufficiency in human cells containing a germline mutation in Ukraine on the Radiological Consequences of the Chernobyl Accident. BRCA1 or BRCA2. Int J Cancer 97:557-561. Minsk, Belarus. Buchhop, S., M.K. Gibson, X.W. Wang, P. Wagner, H.W. Sturzbecher, and Cardis, E., and D. Richardson. 2000. Invited editorial: health effects of C.C. Harris. 1997. Interaction of p53 with the human Rad51 protein. radiation exposure at uranium processing facilities. J Radiol Prot 20: Nucleic Acids Res 25:3868-3874. 95-97. Budarf, M.L., and B.S. Emanuel. 1997. Progress in the autosomal segmen- Cardis, E., E.S. Gilbert, L. Carpenter, G. Howe, I. Kato, B.K. Armstrong, tal aneusomy syndromes (SASs): single or multi-locus disorders? Hum V. Beral, G. Cowper, A. Douglas, J. Fix, F.A. Fry, J. Kaldor, C. Lave, L. Mol Genet 6:1657-1665. Salmon, P.G. Smith, G.L. Voelz, and L.D. Wiggs. 1995. Effects of low Burak, L.E., Y. Kodama, M. Nakano, K. Ohtaki, M. Itoh, N.D. Okladnikova, doses and low dose rates of external ionizing radiation: cancer mortality E.K. Vasilenko, J.B. Cologne, and N. Nakamura. 2001. FISH examina- among nuclear industry workers in three countries. Radiat Res 142:117- tion of lymphocytes from Mayak workers for assessment of transloca- 132. tion induction rate under chronic radiation exposures. Int J Radiat Biol Cardis, E., A.E. Okeanov, L. Anspaugh, V.K. Ivanov, I. Likthariev, A.E. 77:901-908. Okeanov, and A. Prisyazhniuk. 1996. Estimated long term health ef- Burki, H.J. 1980. Ionizing radiation-induced 6-thioguanine-resistant clones fects of the Chernobyl accident. Pp. 241-279 in Proceedings of the Joint in synchronous CHO cells. Radiat Res 81:76-84. EU, IAEA and WHO International Conference One Decade after Burma, S., B.P. Chen, M. Murphy, A. Kurimasa, and D.J. Chen. 2001. Chernobyl. Vienna, Austria. ATM phosphorylates histone H2AX in response to DNA double-strand Cardis, E., D. Richardson, and A. Kesminiene. 2000. Radiation Risk Esti- breaks. J Biol Chem 276:42462-42467. mates in the Beginning of the 21st Century. Bethesda, MD: National Council on Radiation Protection and Measurements.

OCR for page 337
342 REFERENCES Cardis, E., M. Vrijheid, M. Blettner, E. Gilbert, M. Hakama, C. Hill, G. Cattanach, B.M., M.D. Burtenshaw, C. Rasberry, and E.P. Evans. 1993. Howe, J. Kaldor, C.R. Muirhead, M. Schubauer-Berigan, Yoshimura, Large deletions and other gross forms of chromosome imbalance com- F. Bermann, G. Cowper, J. Fix, C. Hacker, B. Heinmiller, M. Marshall, patible with viability and fertility in the mouse. Nat Genet 3:56-61. I. Thierry-Chef, D. Utterback, Y.O. Ahn, E. Amoros, P. Ashmore, A. Cattanach, B.M., E.P. Evans, C. Rasberry, and M.D. Burtenshaw. 1996. Auvinen, J.M. Bae, J. Bernar Solano, A. Biau, E. Combalot, P. Deboodt, Incidence and distribution of radiation-induced large deletions in the A. Diez Sacristan, M. Eklof, H. Engels, G. Engholm, G. Gulis, R. Habib, mouse. Pp. 531-534 in Radiation Research 1895-1995, Vol. 2, Proceed- K. Holan, H. Hyvonen, A. Kerekes, J. Kurtinaitis, H. Malker, M. ings of the 10th International Congress of Radiation Research, Martuzzi, A. Mastauskas, A. Monnet, M. Moser, M. Murata, M.S. Wurzburg, August 27-September 1, 1995. Pearce, D.B. Richardson, F. Rodriguez-Artalejo, A. Rogel, H. Tardy, Chakraborty, R., M.P. Little, and K. Sankaranarayanan. 1997. Cancer pre- M. Telle-Lamberton, I. Turai, M. Usel, and K. Veress. 2005a. Cancer disposition, radiosensitivity and the risk of radiation-induced cancers. risk following low doses of ionising radiation—a 15-country study. Brit III. Effects of incomplete penetrance and dose-dependent radiosensitiv- Med J. ity on cancer risks in populations. Radiat Res 147:309-320. Cardis, E., A. Kesminiene, V. Ivanov, I. Malakhova, Y. Shibata, V. Chakraborty, R., M.P. Little, and K. Sankaranarayanan. 1998a. Cancer pre- Khrouch, V. Drozdovitch, E. Maceika, I. Zvonova, O. Vlassov, A. disposition, radiosensitivity and the risk of radiation-induced cancers. Bouville, G. Goulko, M. Hoshi, A. Abrosimov, J. Anoshko, L. IV. Prediction of risks in relatives of cancer-predisposed individuals. Astakhova, S. Chekin, E. Demidchik, R. Galanti, M. Ito, E. Korobova, Radiat Res 149:493-507. E. Lushnikov, M. Maksioutov, V. Masyakin, A. Nerovnia, V. Parshin, Chakraborty, R., N. Yasuda, C. Denniston, and K. Sankaranarayanan. E. Parshkov, N. Piliptsevich, A. Pinchera, S. Polyakov, N. Shabeka, E. 1998b. Ionizing radiation and genetic risks. VII. The concept of muta- Suonio, V. Tenet, A. Tsyb, S. Yamashita, and D. Williams. 2005b. Risk tion component and its use in risk estimation for Mendelian diseases. of thyroid cancer after exposure to 131I in childhood. J Natl Cancer Inst Mutat Res 400:541-552. 97:724-732. Chan, T.A., H. Hermeking, C. Lengauer, K.W. Kinzler, and B. Vogelstein. Carnes, B.A., and T.E. Fritz. 1991. Responses of the beagle to protracted 1999. 14-3-3 Sigma is required to prevent mitotic catastrophe after DNA irradiation. I. Effect of total dose and dose rate. Radiat Res 128:125- damage. Nature 401:616-620. 132. Chang, B.D., K. Watanabe, E.V. Broude, J. Fang, J.C. Poole, T.V. Carnes, B.A., D. Grahn, and J.F. Thomson. 1989. Dose-response modeling Kalinichenko, and I.B. Roninson. 2000. Effects of p21Waf1/Cip1/Sdi1 of life shortening in a retrospective analysis of the combined data from on cellular gene expression: implications for carcinogenesis, senes- the JANUS program at Argonne National Laboratory. Radiat Res cence, and age-related diseases. Proc Natl Acad Sci USA 97:4291-4296. 119:39-56. Chang, B.H., L.C. Shimmin, S.K. Shyue, D. Hewett-Emmett, and W.H. Li. Carnes, B.A., S.J. Olshansky, and D. Grahn. 1998. An interspecies predic- 1994. Weak male-driven molecular evolution in rodents. Proc Natl Acad tion of the risk of radiation-induced mortality. Radiat Res 149:487-492. Sci USA 91:827-831. Carnes, B.A., N. Gavrilova, and D. Grahn. 2002. Pathology effects at radia- Chang, S., C. Khoo, and R.A. DePinho. 2001. Modeling chromosomal in- tion doses below those causing increased mortality. Radiat Res 158:187- stability and epithelial carcinogenesis in the telomerase-deficient mouse. 194. Semin Cancer Biol 11:227-239. Carnes, B.A., D. Grahn, and D. Hoel. 2003. Mortality of atomic bomb sur- Chang, W.P., and J.B. Little. 1992. Evidence that DNA double-strand breaks vivors predicted from laboratory animals. Radiat Res 160:159-167. initiate the phenotype of delayed reproductive death in Chinese hamster Carpenter, L., P. Fraser, M. Booth, C. Higgins, and V. Beral. 1989. Smok- ovary cells. Radiat Res 131:53-59. ing habits and radiation exposure. J Radiol Prot 9:286-287. Charles, D.J., and W. Pretsch. 1986. Enzyme-activity mutations detected in Carpenter, L., V. Beral, P. Fraser, and M. Booth. 1990. Health related selec- mice after paternal fractionated irradiation. Mutat Res 160:243-248. tion and death rates in the United Kingdom Atomic Energy Authority Chauveinc, L., M. Ricoul, L. Sabatier, G. Gaboriaud, A. Srour, X. Bertagna, workforce. Brit J Ind Med 47:248-258. and B. Dutrillaux. 1997. Dosimetric and cytogenetic studies of multiple Carpenter, L., C. Higgins, A. Douglas, P. Fraser, V. Beral, and P. Smith. radiation-induced meningiomas for a single patient. Radiother Oncol 1994. Combined analysis of mortality in three United Kingdom nuclear 43:285-288. industry workforces, 1946-1988. Radiat Res 138:224-238. Checkoway, H., R.M. Mathew, C.M. Shy, J.E. Watson Jr., W.G. Tankersley, Carpenter, L.M., C.D. Higgins, A.J. Douglas, N.E. Maconochie, R.Z. Omar, S.H. Wolf, J.C. Smith, and S.A. Fry. 1985. Radiation, work experience, P. Fraser, V. Beral, and P.G. Smith. 1998. Cancer mortality in relation and cause specific mortality among workers at an energy research labo- to monitoring for radionuclide exposure in three UK nuclear industry ratory. Brit J Ind Med 42:525-533. workforces. Brit J Cancer 78:1224-1232. Checkoway, H., N. Pearce, D.J. Crawford-Brown, and D.L. Cragle. 1988. Carr, Z.A., R.A. Kleinerman, M. Stovall, R.M. Weinstock, M.L. Griem, Radiation doses and cause-specific mortality among workers at a nuclear and C.E. Land. 2002. Malignant neoplasms after radiation therapy for materials fabrication plant. Am J Epidemiol 127:255-266. peptic ulcer. Radiat Res 157:668-677. Chehab, N.H., A. Malikzay, M. Appel, and T.D. Halazonetis. 2000. Chk2/ Carrano, A.V., and J.A. Heddle. 1973. The fate of chromosome aberrations. hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing J Theor Biol 38:289-304. p53. Gene Dev 14:278-288. Carter, C.O. 1961. The inheritance of pyloric stenosis. Brit Med Bull Chenevix-Trench, G., A.B. Spurdle, M. Gatei, H. Kelly, A. Marsh, X. Chen, 17:251-254. K. Donn, M. Cummings, D. Nyholt, M.A. Jenkins, C. Scott, G.M. Pupo, Carter, C.O. 1976a. Genetics of common single malformations. Brit Med T. Dork, R. Bendix, J. Kirk, K. Tucker, M.R. McCredie, J.L. Hopper, J. Bull 32:21-26. Sambrook, G.J. Mann, and K.K. Khanna. 2002. Dominant negative Carter, C.O. 1976b. Monogenic disorders. J Med Genet 14:316-320. ATM mutations in breast cancer families. J Natl Cancer Inst 94: Cattanach, B.M., and H. Moseley. 1974. Sterile period, translocation and 205-215. specific locus mutation in the mouse following fractionated x-ray treat- Cherbonnel-Lasserre, C., S. Gauny, and A. Kronenberg. 1996. Suppression ments with different fractionation intervals. Mutat Res 25:63-72. of apoptosis by Bcl-2 or Bcl-xL promotes susceptibility to mutagenesis. Cattanach, B.M., and C. Rasberry. 1994. Enhanced specific-locus mutation Oncogene 13:1489-1497. response of 101/H male mice to single, acute X-irradiation. Mutat Res Childs, J.D. 1981. The effect of a change in mutation rate on the incidence 311:77-84. of dominant and X-linked recessive disorders in man. Mutat Res 83: Cattanach, B.M., C. Jones, and D.G. Papworth. 1985. Specific-locus muta- 145-158. tion response to unequal, 1 + 9 Gy X-ray fractionations at 24-h and 4- day fraction intervals. Mutat Res 149:105-118.

OCR for page 337
REFERENCES 343 Choi, H., S. Kim, P. Mukhopadhyay, S. Cho, J. Woo, G. Storz, and S. Ryu. Court Brown, W.M., and R. Doll. 1958. Expectation of life and mortality 2001. Structural basis of the redox switch in the OxyR transcription from cancer among British radiologists. Brit Med J:181-187. factor. Cell 105:103-113. Coussens, L.M., and Z. Werb. 2002. Inflammation and cancer. Nature Chuang, Y.Y., and H.L. Liber. 1996. Effects of cell cycle position on ioniz- 420:860-867. ing radiation mutagenesis. I. Quantitative assays of two genetic loci in a Covelli, V., V. Di Majo, M. Coppola, and S. Rebessi. 1989. The dose- human lymphoblastoid cell line. Radiat Res 146:494-500. response relationships for myeloid leukemia and malignant lymphoma Clark, D.J., E.I.M. Meijne, S.D. Bouffler, R. Huiskamp, C.J. Skidmore, R. in BC3F1 mice. Radiat Res 119:553-561. Cox, and A.R.J. Silver. 1996. Microsatellite analysis of recurrent chro- Cox, R., and A.A. Edwards. 2002. Comments on the paper: Microsatellite mosome 2 deletions in acute myeloid leukaemia induced by radiation in instability in acute myelocytic leukaemia developed from A-bomb sur- F1 hybrid mice. Gene Chromosome Canc 16:238-246. vivors—and related cytogenic data. Int J Radiat Biol 78:443-445. Clayton, D., and M. Hills. 1993. Statistical Methods in Epidemiology. New Cox, R., and W.K. Masson. 1978. Do radiation-induced thioguanine-resis- York: Oxford Press. tant mutants of cultured mammalian cells arise by HGPRT gene muta- Cleaver, J.E. 1968. Defective repair replication of DNA in xeroderma tion or X-chromosome rearrangement? Nature 276:629-630. pigmentosum. Nature 218:652-656. Cox, R., and W.K. Masson. 1979. Mutation and inactivation of cultured Clifton, K.H. 1996. Comments on the evidence in support of the epigenetic mammalian cells exposed to beams of accelerated heavy ions. III. Hu- nature of radiogenic initiation. Mutat Res 350:77-80. man diploid fibroblasts. Int J Radiat Biol Re 36:149-160. Clutton, S.M., K.M.S. Townsend, D.T. Goodhead, J.D. Ansell, and E.G. Cox, R., J. Thacker, and D.T. Goodhead. 1977. Inactivation and mutation of Wright. 1996a. Differentiation and delayed cell death in embryonal stem cultured mammalian cells by aluminium characteristic ultrasoft x-rays. cells exposed to low doses of ionising radiation. Cell Death Differ 3: II. Dose-responses of Chinese hamster and human diploid cells to alu- 141-148. minium x-rays and radiations of different LET. Int J Radiat Biol Re Clutton, S.M., K.M.S. Townsend, C. Walker, J.D. Ansell, and E.G. Wright. 31:561-576. 1996b. Radiation-induced genomic instability and persisting oxidative Cragle, D.L., R.W. McLain, J.R. Qualters, J.L. Hickey, G.S. Wilkinson, stress in primary bone marrow cultures. Carcinogenesis 17:1633-1639. W.G. Tankersley, and C.C. Lushbaugh. 1988. Mortality among workers Cohen, B.L. 2002. Cancer risk from low-level radiation. Am J Roentgenol- at a nuclear fuels production facility. Am J Ind Med 14:379-401. ogy 179:1137-1143. Cragle, D.L., K. Robertson-Demers, and J.P. Watkins. 1994. Mortality Collis, S.J., J.M. Schwaninger, A.J. Ntambi, T.W. Keller, W.G. Nelson, among Workers at a Nuclear Fuels Production Facility: The Savannah L.E. Dillehay, and T.L. Deweese. 2004. Evasion of early cellular re- River Site, 1952-1986. Center for Epidemiologic Research. Oak Ridge, sponse mechanisms following low level radiation-induced DNA dam- TN: Oak Ridge Institute for Science and Education. age. J Biol Chem 279:49624-49632. Critchlow, S.E., and S.P. Jackson. 1998. DNA end-joining: from yeast to Cologne, J.B., and D.L. Preston. 2000. Longevity of atomic-bomb survi- man. Trends Biochem Sci 23:394-398. vors. Lancet 356:303-307. Crompton, N.E.A., B. Barth, and J. Kiefer. 1990. Inverse dose-rate effect Cologne, J.B., S. Tokuoka, G.W. Beebe, T. Fukuhara, and K. Mabuchi. for the induction of 6-thioguanine-resistant mutants in Chinese hamster 1999. Effects of radiation on incidence of primary liver cancer among V79-S cells by 60Co gamma rays. Radiat Res 124:300-308. atomic bomb survivors. Radiat Res 152:364-373. Crow, J.F. 1993. How much do we know about spontaneous human muta- Conard, R.A. 1980. Review of Medical Findings in a Marshallese Popula- tion rates? Environ Mol Mutagen 21:122-129. tion Twenty-Six Years after Accidental Exposure to Radioactive Fall- Crow, J.F. 1997. The high spontaneous mutation rate: is it a health risk? out. Upton, NY: Brookhaven National Laboratory. Proc Natl Acad Sci USA 94:8380-8386. Conard, R.A. 1984. Late radiation effects in Marshall Islanders exposed to Crow, J.F. 1999. Spontaneous mutation in man. Mutat Res 437:5-9. fallout 28 years ago. Pp. 57-71 in Radiation Carcinogenesis: Epidemiol- Crow, J.F. 2001. The beanbag lives on. Nature 409:771. ogy and Biologic Significance, J.D. Boice Jr. and J.F. Fraumeni Jr., eds. Crow, J.F., and C. Denniston. 1981. The mutation component of genetic New York: Raven Press. damage. Science 212:888-893. Congdon, C.C. 1987. A review of certain low-level ionizing radiation stud- Crow, J.F., and C. Denniston. 1985. Mutations in human populations. Adv ies in mice and guinea pigs. Health Phys 52:593-597. Hum Genet 14:59-123. Connor, F., D. Bertwistle, P.J. Mee, G.M. Ross, S. Swift, E. Grigorieva, Curtis, R.E., J.D. Boice Jr., M. Stovall, L. Bernstein, R.S. Greenberg, J.T. V.L. Tybulewicz, and A. Ashworth. 1997. Tumorigenesis and a DNA Flannery, A.G. Schwartz, P. Weyer, W.C. Moloney, and R.N. Hoover. repair defect in mice with a truncating Brca2 mutation. Nat Genet 1992. Risk of leukemia after chemotherapy and radiation treatment for 17:423-430. breast cancer. N Engl J Med 326:1745-1751. Cormier, R.T., A. Bilger, A.J. Lillich, R.B. Halberg, K.H. Hong, K.A. Curtis, R.E., J.D. Boice Jr., M. Stovall, L. Bernstein, E. Holowaty, S. Gould, N. Borenstein, E.S. Lander, and W.F. Dove. 2000. The Karjalainen, F. Langmark, P.C. Nasca, A.G. Schwartz, and M.J. Mom1AKR intestinal tumor resistance region consists of Pla2g2a and a Schymura. 1994. Relationship of leukemia risk to radiation dose fol- locus distal to D4Mit64. Oncogene 19:3182-3192. lowing cancer of the uterine corpus. J Natl Cancer Inst 86:1315-1324. Cornforth, M.N., and J.S. Bedford. 1983. X-ray-induced breakage and re- Czeizel, A., and K. Sankaranarayanan. 1984. The load of genetic and par- joining of human interphase chromosomes. Science 222:1141-1143. tially genetic disorders in man. I. Congenital anomalies: estimates of Cornforth, M.N., and J.S. Bedford. 1987. A quantitative comparison of po- detriment in terms of years of life lost and years of impaired life. Mutat tentially lethal damage repair and the rejoining of interphase chromo- Res 128:73-103. some breaks in low passage normal human fibroblasts. Radiat Res Czeizel, A., and G. Tusnady. 1984. Aetiological Studies of Isolated Com- 111:385-405. mon Congenital Abnormalities in Hungary. Budapest: Akademiai Cornforth, M.N., and J.S. Bedford. 1993. Ionizing radiation damage and its Kiado. early development in chromosomes. Adv Radiat Biol 423:423-496. Czeizel, A., K. Sankaranarayanan, A. Losonci, T. Rudas, and M. Keresztes. Cornforth, M.N., S.M. Bailey, and E.H. Goodwin. 2002. Dose responses 1988. The load of genetic and partially genetic diseases in man. II. Some for chromosome aberrations produced in noncycling primary human selected common multifactorial diseases: estimates of detriment in terms fibroblasts by alpha particles and by gamma rays delivered at of years lost and impaired life. Mutat Res 196:259-292. sublimiting low dose rates. Radiat Res 158:43-53. Czene, K., P. Lichtenstein, and K. Hemminki. 2002. Environmental and Correa, C.R., and V.G. Cheung. 2004. Genetic variation in radiation-in- heritable causes of cancer among 9.6 million individuals in the Swedish duced expression phenotypes. Am J Hum Genet 75:885-890. Family-Cancer Database. Int J Cancer 99:260-266.

OCR for page 337
344 REFERENCES Dalager, N.A., H.K. Kang, and C.M. Mahan. 2000. Cancer mortality among Deng, C.X., and S.G. Brodie. 2001. Knockout mouse models and mammary the highest exposed US atmospheric nuclear test participants. J Occup tumorigenesis. Semin Cancer Biol 11:387-394. Environ Med 42:798-805. Denniston, C. 1983. Are human studies possible? Some thoughts on the Damber, L., L.G. Larsson, L. Johansson, and T. Norin. 1995. A cohort mutation component and population monitoring. Environ Health Persp study with regard to the risk of haematological malignancies in patients 52:41-44. treated with x-rays for benign lesions in the locomotor system. I. Epide- Denniston, C., R. Chakraborty, and K. Sankaranarayanan. 1998. Ionizing miological analyses. Acta Oncol 34:713-719. radiation and genetic risks. VIII. The concept of mutation component Darby, S.C., G.M. Kendall, T.P. Fell, R. Doll, A.A. Goodill, A.J. Conquest, and its use in risk estimation for multifactorial diseases. Mutat Res D.A. Jackson, and R.G. Haylock. 1993. Further follow up of mortality 405:57-79. and incidence of cancer in men from the United Kingdom who partici- Dent, P., D.B. Reardon, J.S. Park, G. Bowers, C. Logsdon, K. Valerie, and pated in the United Kingdom’s atmospheric nuclear weapon tests and R. Schmidt-Ullrich. 1999. Radiation-induced release of transforming experimental programmes. Brit Med J 307:1530-1535. growth factor alpha activates the epidermal growth factor receptor and Darby, S.C., G. Reeves, T. Key, R. Doll, and M. Stovall. 1994. Mortality in mitogen-activated protein kinase pathway in carcinoma cells, leading to a cohort of women given x-ray therapy for metropathia haemorrhagica. increased proliferation and protection from radiation-induced cell death. Int J Cancer 56:793-801. Mol Biol Cell 10:2493-2506. Darby, S., P. McGale, R. Peto, F. Granath, P. Hall, and A. Ekbom. 2003. DerSimonian, R., and N. Laird. 1986. Meta-analysis in clinical trials. Con- Mortality from cardiovascular disease more than 10 years after radio- trol Clin Trials 7:177-188. therapy for breast cancer: nationwide cohort study of 90,000 Swedish Dewey, W.C., R.M. Humphrey, and B.A. Jones. 1965. Comparisons of tri- women. Brit Med J 326:256-257. tiated thymidine, tritiated water, and cobalt-60 gamma rays in inducing Darroudi, F., J. Fomina, M. Meijers, and A.T. Natarajan. 1998. Kinetics of chromosomal aberrations. Radiat Res 24:214-238. the formation of chromosome aberrations in x-irradiated human lym- Dewey, W.C., S.C. Furman, and H.H. Miller. 1970. Comparison of lethality phocytes, using PCC and FISH. Mutat Res 404:55-65. and chromosomal damage induced by x-rays in synchronized Chinese Davis, F., J. Boice, Z. Hrubec, and R. Monson. 1989. Cancer mortality in a hamster cells in vitro. Radiat Res 43:561-581. radiation-exposed cohort of Massachusetts. Cancer Res 49:6130-6136. Dianov, G.L., R. Prasad, S.H. Wilson, and V.A. Bohr. 1999. Role of DNA Davis, S., K.J. Kopecky, and T.E. Hamilton. 2001. Final Report. Hanford polymerase beta in the excision step of long patch mammalian base Thyroid Disease Study. excision repair. J Biol Chem 274:13741-13743. Davis S., K.J. Kopecky, T.E. Hamilton, and L.E. Onstad. 2004a. Thyroid Dickinson, H.O., L. Parker, K. Binks, R. Wakeford, and J. Smith. 1996. The neoplasia, autoimmune thyroiditis, and hypothyroidism in persons ex- sex ratio of children in relation to paternal preconceptional radiation posed to I-131 from the Hanford Nuclear Site. J Am Med Assoc dose: a study in Cumbria, Northern England. J Epidemiol Commun H 292:2600-2613. 50:645-652. Davis, S., V. Stepanenko, N. Rivkind, K.J. Kopecky, P. Voilleque, V. Difilippantonio, M.J., S. Petersen, H.T. Chen, R. Johnson, M. Jasin, R. Shakhtarin, E. Parshkov, S. Kulikov, E. Lushnikov, A. Abrosimov, V. Kanaar, T. Ried, and A. Nussenzweig. 2002. Evidence for replicative Troshin, G. Romanova, V. Doroschenko, A. Proshin, and A. Tsyb. repair of DNA double-strand breaks leading to oncogenic translocation 2004b. Risk of thyroid cancer in the Bryansk Oblast of the Russian and gene amplification. J Exp Med 196:469-480. Federation after the Chernobyl Power Station accident. Radiat Res Dizdaroglu, M. 1992. Oxidative damage to DNA in mammalian chromatin. 162:241-248. Mutat Res 275:331-342. Day, J.P., C.L. Limoli, and W.F. Morgan. 1998. Recombination involving Dizdaroglu, M., M.L. Dirksen, H.X. Jiang, and J.H. Robbins. 1987. Ioniz- interstitial telomere repeat-like sequences promotes chromosomal in- ing-radiation-induced damage in the DNA of cultured human cells. Iden- stability in Chinese hamster cells. Carcinogenesis 19:259-265. tification of 8,5-cyclo-2-deoxyguanosine. Biochem J 241:929-932. Daza, P., S. Reichenberger, B. Gottlich, M. Hagmann, E. Feldmann, and P. Dizdaroglu, M., Z. Nackerdien, B.C. Chao, E. Gajewski, and G. Rao. 1991. Pfeiffer. 1996. Mechanisms of nonhomologous DNA end-joining in Chemical nature of in vivo DNA base damage in hydrogen peroxide- frogs, mice and men. Biol Chem 377:775-786. treated mammalian cells. Arch Biochem Biophys 285:388-390. de Vathaire, F., P. Francois, C. Hill, O. Schweisguth, C. Rodary, D. Sarrazin, Dobson, R.L., T. Straume, A.V. Carrano, J.L. Minkler, L.L. Deaven, L.G. O. Oberlin, C. Beurtheret, A. Dutreix, and R. Flamant. 1989. Role of Littlefield, and A.A. Awa. 1991. Biological effectiveness of neutrons radiotherapy and chemotherapy in the risk of second malignant neo- from Hiroshima bomb replica: results of a collaborative cytogenetic plasms after cancer in childhood. Brit J Cancer 59:792-796. study. Radiat Res 128:143-149. de Vathaire, F., M. Schlumberger, M.J. Delisle, C. Francese, C. Challeton, Dobyns, B.M., G.E. Sheline, J.B. Workman, E.A. Tompkins, W.M. E. de la Genardiere, F. Meunier, C. Parmentier, C. Hill, and H. Sancho- McConahey, and D.V. Becker. 1974. Malignant and benign neoplasms Garnier. 1997. Leukaemias and cancers following iodine-131 adminis- of the thyroid in patients treated for hyperthyroidism: a report of the tration for thyroid cancer. Brit J Cancer 75:734-739. cooperative thyrotoxicosis therapy follow-up study. J Clin Endocr de Vathaire, F., M. Hawkins, S. Campbell, O. Oberlin, M.A. Raquin, J.Y. Metab 38:976-998. Schlienger, A. Shamsaldin, I. Diallo, J. Bell, E. Grimaud, C. Hardiman, Doll, R., and R. Wakeford. 1997. Risk of childhood cancer from fetal irra- J.L. Lagrange, N. Daly-Schveitzer, X. Panis, J.M. Zucker, H. Sancho- diation. Brit J Radiol 70:130-139. Garnier, F. Eschwege, J. Chavaudra, and J. Lemerle. 1999. Second ma- Dondon, M.G., F. de Vathaire, A. Shamsaldin, F. Doyon, I. Diallo, L. Ligot, lignant neoplasms after a first cancer in childhood: temporal pattern of C. Paoletti, M. Labbe, M. Abbas, J. Chavaudra, M.F. Avril, P. Fragu, risk according to type of treatment. Brit J Cancer 79:1884-1893. and F. Eschwege. 2004. Cancer mortality after radiotherapy for a skin Degg, N.L., M.M. Weil, A. Edwards, J. Haines, M. Coster, J. Moody, M. hemangioma during childhood. Radiother Oncol 72:87-93. Ellender, R. Cox, and A. Silver. 2003. Adenoma multiplicity in irradi- Dong, C., and K. Hemminki. 2001. Modification of cancer risks in off- ated Apc(Min) mice is modified by chromosome 16 segments from spring by sibling and parental cancers from 2,112,616 nuclear families. BALB/c. Cancer Res 63:2361-2363. Int J Cancer 92:144-150. Delongchamp, R.R., K. Mabuchi, Y. Yoshimoto, and D.L. Preston. 1997. Doody, M.M., J.S. Mandel, J.H. Lubin, and J.D. Boice Jr. 1998. Mortality Cancer mortality among atomic bomb survivors exposed in utero or as among United States radiologic technologists, 1926-90. Cancer Cause young children, October 1950-May 1992. Radiat Res 147:385-395. Control 9:67-75. Demple, B. 1991. Regulation of bacterial oxidative stress genes. Ann Rev Doody, M.M., J.E. Lonstein, M. Stoval, D.G. Hacker, N. Luckyanov, and Genet 25:315-337. C.E. Land. 2000. Breast cancer mortality after diagnostic radiography: findings from the US Scoliosis Cohort Study. Spine 25:2052-2063.

OCR for page 337
REFERENCES 345 Dores, G.M., C. Metayer, R.E. Curtis, C.F. Lynch, E.A. Clarke, B. Duensing, S., and K. Munger. 2001. Centrosome abnormalities, genomic Glimelius, H. Storm, E. Pukkala, F.E. van Leeuwen, E.J. Holowaty, M. instability and carcinogenic progression. Biochim Biophys Acta Andersson, T. Wiklund, T. Joensuu, M.B. van’t Veer, M. Stovall, M. 1471:M81-M88. Gospodarowicz, and L.B. Travis. 2002. Second malignant neoplasms Duensing, S., A. Duensing, C.P. Crum, and K. Munger. 2001. Human among long-term survivors of Hodgkin’s disease: a population-based papillomavirus type 16 E7 oncoprotein-induced abnormal centrosome evaluation over 25 years. J Clin Oncol 20:3484-3494. synthesis is an early event in the evolving malignant phenotype. Cancer Douglas, A.J., R.Z. Omar, and P.G. Smith. 1994. Cancer mortality and Res 61:2356-2360. morbidity among workers at the Sellafield plant of British Nuclear Fu- Dugan, L.C., and J.S. Bedford. 2003. Are chromosomal instabilities in- els. Brit J Cancer 70:1232-1243. duced by exposure of cultured normal human cells to low- or high-LET Doyle, P., N. Maconochie, E. Roman, G. Davies, P.G. Smith, and V. Beral. radiation? Radiat Res 159:301-311. 2000. Fetal death and congenital malformation in babies born to nuclear Dummer, T.J., H.O. Dickinson, M.S. Pearce, M.E. Charlton, J. Smith, J. industry employees: report from the nuclear industry family study. Lan- Salotti, and L. Parker. 1998. Stillbirth rates around the nuclear installa- cet 356:1293-1299. tion at Sellafield, North West England: 1950-1989. Int J Epidemiol Draper, G.J., M.P. Little, T. Sorahan, L.J. Kinlen, K.J. Bunch, A.J. Con- 27:74-82. quest, G.M. Kendall, G.W. Kneale, R.J. Lancashire, C.R. Muirhead, Duncan, K.P., and R.W. Howell. 1970. Health workers in the United King- C.M. O’Connor, and T.J. Vincent. 1997. Cancer in the offspring of ra- dom Atomic Energy Authority. Health Phys 19:285-291. diation workers: a record linkage study. Brit Med J 315:1181-1188. Dunning, A.M., C.S. Healey, P.D. Pharoah, M.D. Teare, B.A. Ponder, and Drost, J.B., and W.R. Lee. 1995. Biological basis of germline mutation: D.F. Easton. 1999. A systematic review of genetic polymorphisms and comparisons of spontaneous germline mutation rates among drosophila, breast cancer risk. Cancer Epidemiol Biomarkers Prev 8:843-854. mouse, and human. Environ Mol Mutagen 25(Suppl 26):48-64. Dupree, E.A., D.L. Cragle, R.W. McLain, D.J. Crawford-Brown, and M.J. Dublin, L.I., and M. Spigelman. 1948. Mortality among medical special- Teta. 1987. Mortality among workers at a uranium processing facility, ists. J Am Med Assoc 137:1519-1524. the Linde Air Products Company Ceramics Plant, 1943-1949. Scand J Dubrova, Y.E., A.J. Jeffreys, and A.M. Malashenko. 1993. Mouse Work Env Health 13:100-107. minisatellite mutations induced by ionizing radiation. Nat Genet 5: Dupree, E.A., J.P. Watkins, J.N. Ingle, P.W. Wallace, C.M. West, and W.G. 92-94. Tankersley. 1995. Uranium dust exposure and lung cancer risk in four Dubrova, Y.E., V.N. Nesterov, N.G. Krouchinsky, V.A. Ostapenko, R. uranium processing operations. Epidemiology 6:370-375. Neumann, D.L. Neil, and A.J. Jeffreys. 1996. Human minisatellite mu- Easton, D.F. 1994. Cancer risks in A-T heterozygotes. Int J Radiat Biol tation rate after the Chernobyl accident. Nature 380:683-686. 66:S177-S182. Dubrova, Y.E., V.N. Nesterov, N.G. Krouchinsky, V.A. Ostapenko, G. Eckardt-Schupp, F., and C. Klaus. 1999. Radiation inducible DNA repair Vergnaud, F. Giraudeau, J. Buard, and A.J. Jeffreys. 1997. Further evi- processes in eukaryotes. Biochimie 81:161-171. dence for elevated human minisatellite mutation rate in Belarus eight Edwards, A.A. 1992. Low Dose and Low Dose Rate Effects in Laboratory years after the Chernobyl accident. Mutat Res 381:267-278. Animals, Technical Memorandum 1(92). Chilton, UK: National Radio- Dubrova, Y.E., M. Plumb, J. Brown, J. Fennelly, P. Bois, D. Goodhead, and logical Protection Board. A.J. Jeffreys. 1998a. Stage specificity, dose response, and doubling dose Edwards, A.A., and R. Cox. 2000. Commentary on the Second Event Theory for mouse minisatellite germ-line mutation induced by acute radiation. of Busby. Int J Radiat Biol 76:119-122. Proc Natl Acad Sci USA 95:6251-6255. Edwards, A.A., and J.R. Savage. 1999. Is there a simple answer to the ori- Dubrova, Y.E., M. Plumb, J. Brown, and A.J. Jeffreys. 1998b. Radiation- gin of complex chromosome exchanges? Int J Radiat Biol 75:19-22. induced germline instability at minisatellite loci. Int J Radiat Biol Edwards, A.A., D.C. Lloyd, R.J. Purrott, and J.C. Prosser. 1982. The 74:689-696. dependence of chromosome aberration yields on dose rate and radiation Dubrova, Y.E., M. Plumb, J. Brown, E. Boulton, D. Goodhead, and A.J. quality. In: Research and Development Report, 1979-1981, R&D 4. Jeffreys. 2000a. Induction of minisatellite mutations in the mouse Chilton, UK: National Radiological Protection Board. germline by low-dose chronic exposure to gamma-radiation and fission Edwards, A.A., D.C. Lloyd, and J.S. Prosser. 1989. Chromosome aberra- neutrons. Mutat Res 453:17-24. tions in human lymphocytes—a radiobiological review. Pp. 423-432 in Dubrova, Y.E., M. Plumb, B. Gutierrez, E. Boulton, and A.J. Jeffreys. Low Dose Radiation: Biological Bases of Risk Assessment, K.F. 2000b. Transgenerational mutation by radiation. Nature 405:37. Baverstock and J.W. Stather, eds. London: Taylor and Francis. Dubrova, Y.E., R.I. Bersimbaev, L.B. Djansugurova, M.K. Tankimanova, Eeles, R., B. Bonder, D. Easton, and A. Horwich. 1996. Genetic Predispo- Z.Zh. Mamyrbaeva, R. Mustonen, C. Lindholm, M. Hulten, and S. sition to Cancer. London: Chapman and Hall. Salomaa. 2002a. Nuclear weapons tests and human germline mutation Ehling, U.H. 1965. The frequency of x-ray-induced dominant mutations rate. Science 295:1037. affecting the skeleton in mice. Genetics 51:723-732. Dubrova, Y.E., G. Grant, A.A. Chumak, V.A. Stezhka, and A.N. Ehling, U.H. 1966. Dominant mutations affecting the skeletion in offspring Karakasian. 2002b. Elevated minisatellite mutation rate in the post- of x-irradiated male mice. Genetics 54:1381-1389. Chernobyl families from Ukraine. Am J Hum Genet 71:801-809. Ehling, U.H. 1985. Induction and manifestation of hereditary cataracts. Ducray, C., J.P. Pommier, L. Martins, F.D. Boussin, and L. Sabatier. 1999. Basic Life Sci 33:345-367. Telomere dynamics, end-to-end fusions and telomerase activation dur- Elkind, M.M. 1996. Guest editorial: enhanced risks of cancer from pro- ing the human fibroblast immortalization process. Oncogene 18:4211- tracted exposures to x- or gamma-rays: a radiobiological model of ra- 4223. diation-induced breast cancer. Brit J Cancer 73:133-138. Duell, E.J., J.K. Wiencke, T.J. Cheng, A. Varkonyi, Z.F. Zuo, T.D. Ashok, Ellegren, H. 2000. Microsatellite mutations in the germline: implications E.J. Mark, J.C. Wain, D.C. Christiani, and K.T. Kelsey. 2000. Polymor- for evolutionary inference. Trends Genet 16:551-558. phisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of Ellender, M., S.M. Larder, and J.D. Harrison. 1997. Radiation-induced in- DNA damage in human blood mononuclear cells. Carcinogenesis testinal neoplasia in a genetically-predisposed mouse (Min). Radiopro- 21:965-971. tection 32:C1-C287. Duell, E.J., R.C. Millikan, G.S. Pittman, S. Winkel, R.M. Lunn, C.K. Tse, Elson, A., Y. Wang, C.J. Daugherty, C.C. Morton, F. Zhou, J. Campos- A. Eaton, H.W. Mohrenweiser, B. Newman, and D.A. Bell. 2001. Poly- Torres, and P. Leder. 1996. Pleiotropic defects in ataxia-telangiectasia morphisms in the DNA repair gene XRCC1 and breast cancer. Cancer protein-deficient mice. Proc Natl Acad Sci USA 93:13084-13089. Epidemiol Biomarkers Prev 10:217-222. Elston, R.C., and J. Stewart. 1971. A general model for the genetic analysis of pedigree data. Hum Hered 21:523-542.

OCR for page 337
346 REFERENCES Endlich, B., I.R. Radford, H.B. Forrester, and W.C. Dewey. 2000. Comput- Fisher, B., H. Rockette, E.R. Fisher, D.L. Wickerham, C. Redmond, and A. erized video time-lapse microscopy studies of ionizing radiation-in- Brown. 1985. Leukemia in breast cancer patients following adjuvant duced rapid-interphase and mitosis-related apoptosis in lymphoid cells. chemotherapy or postoperative radiation: the NSABP experience. J Clin Radiat Res 153:36-48. Oncol 3:1640-1658. Eng, C., F.P. Li, D.H. Abramson, R.M. Ellsworth, F.L. Wong, M.B. Fisher, R.A. 1918. The correlation between relatives on the supposition of Goldman, J. Seddon, N. Tarbell, and J.D. Boice Jr. 1993. Mortality Mendelian inheritance. Trans Roy Soc Edin 52:399-433. from second tumors among long-term survivors of retinoblastoma. J Fix, J.J., E.S. Gilbert, and W.V. Baumgartner. 1994. An Assessment of Bias Natl Cancer Inst 85:1121-1128. and Uncertainty in Recorded Dose from External Sources of Radiation Engels, H., and A. Wambersie. 1998. Relative biological effectiveness of for Workers at the Hanford Site. PNL-10066. Richland, WA: Pacific neutrons for cancer induction and other late effects: a review of radio- Northwest Laboratory. biological data. Recent Res Cancer 150:54-87. Fix, J.J., L. Salmon, G. Cowper, and E. Cardis. 1997. A retrospective evalu- EPA (Environmental Protection Agency). 1994. Estimating Radiogenic ation of the dosimetry employed in an international combined epide- Cancer Risks, EPA Report 402-R-93-076. Washington DC: U.S. Envi- miological study. Radiat Prot Dosim 74:39-53. ronmental Protection Agency. Fjalling, M., L.E. Tisell, S. Carlsson, G. Hansson, L.M. Lundberg, and A. EPA (Environmental Protection Agency). 1999. Estimating Radiogenic Oden. 1986. Benign and malignant thyroid nodules after neck irradia- Cancer Risks. Addendum: Uncertainty Analysis. Washington DC: U.S. tion. Cancer 58:1219-1224. Environmental Protection Agency. Floyd, R.A. 1995. Measurement of oxidative stress in vivo. Pp. 89-103 in Epstein, C.J. 1995. The new dysmorphology: application of insights from The Oxygen Paradox, K.J.A. Davies and F. Ursini, eds. Padova, Italy: basic developmental biology to the understanding of human birth de- CLEUP University Press. fects. Proc Natl Acad Sci USA 92:8566-8573. Folkman, J. 1995. Angiogenesis in cancer, vascular, rheumatoid and other ESGNWJ (Epidemiological Study Group of Nuclear Workers [Japan]). disease. Nat Med 1:27-31. 1997. First analysis of mortality of nuclear industry workers in Japan, Folley, J.H., W. Borges, and T. Yamasaki. 1952. Incidence of leukemia in 1986-1992. J Health Phys 32:173-184. survivors of the atom bomb in Hiroshima and Nagasaki, Japan. Am J Falconer, D.S. 1965. The inheritance liability to certain diseases, estimated Med 13:311-321. from the incidence among relatives. Ann Hum Genet 29:51-76. Ford, H.L., and A.B. Pardee. 1999. Cancer and the cell cycle. J Cell Biochem Falconer, D.S. 1967. The inheritance of liability to diseases with variable 32-33 (Suppl):166-172. age of onset, with particular reference to diabetes mellitus. Ann Hum Forrester, H.B., C.A. Vidair, N. Albright, C.C. Ling, and W.C. Dewey. Genet 31:1-20. 1999. Using computerized video time lapse for quantifying cell death of Fan, Y.J., Z. Wang, S. Sadamoto, Y. Ninomiya, N. Kotomura, K. Kamiya, x-irradiated rat embryo cells transfected with c-myc or c-Ha-ras. Cancer K. Dohi, R. Kominami, and O. Niwa. 1995. Dose-response of a radia- Res 59:931-939. tion induction of a germline mutation at a hypervariable mouse Fortini, P., B. Pascucci, E. Parlanti, R.W. Sobol, S.H. Wilson, and E. minisatellite locus. Int J Radiat Biol 68:177-183. Dogliotti. 1998. Different DNA polymerases are involved in the short- Favor, J. 1989. Risk estimation based on germ-cell mutations in animals. and long-patch base excision repair in mammalian cells. Biochemistry- Genome 31:844-852. US 37:3575-3580. FCRGERG (FANTOM Consortium and Riken Genome Exploration Re- Fouladi, B., L. Sabatier, D. Miller, G. Pottier, and J.P. Murnane. 2000. The search Group Phase I and II Teams). 2002. Analysis of the mouse relationship between spontaneous telomere loss and chromosome insta- transcriptome based on functional annotation of 60,770 full-length bility in a human tumor cell line. Neoplasia 2:540-554. cDNAs. Nature 420:563-573. Foulds, L. 1975. Neoplastic Development. New York: Acedemic Press. Federal Register. 1987. Radiation protection guidance to federal agencies Franklyn, J.A., P. Maisonneuve, M. Sheppard, J. Betteridge, and P. Boyle. for occupational exposure. Washington, DC: Federal Register 52:2822- 1999. Cancer incidence and mortality after radioiodine treatment for 2834. hyperthyroidism: a population-based cohort study. Lancet 353:2111- Feinberg, A.P. 1993. Genomic imprinting and gene activation in cancer. 2115. Nat Genet 4:110-113. Fraser, P., L. Carpenter, N. Maconochie, C. Higgins, M. Booth, and V. Feinberg, A.P. 2004. The epigenetics of cancer etiology. Semin Cancer Beral. 1993. Cancer mortality and morbidity in employees of the United Biol 14:427-432. Kingdom Atomic Energy Authority, 1946-86. Brit J Cancer 67: Feinberg, S.E. 1988. Method of Statistical Differentials. New York: Wiley- 615-624. Interscience. Freudenreich, C.H., S.M. Kantrow, and V.A. Zakian. 1998. Expansion and Finnon, P., D.C. Lloyd, and A.A. Edwards. 1995. Fluorescence in situ hy- length-dependent fragility of CTG repeats in yeast. Science 279: bridization detection of chromosomal aberrations in human lympho- 853-856. cytes: applicability to biological dosimetry. Int J Radiat Biol 68: Friedberg, W., D.N. Faulkner, L. Snyder, E.B. Darden Jr., and K. O’Brien. 429-435. 1989. Galactic cosmic radiation exposure and associated health risks for Finnon, P., J.E. Moquet, A.A. Edwards, and D.C. Lloyd. 1999. The 60Co air carrier crewmembers. Aviat Space Envir Md 60:1104-1108. gamma ray dose-response for chromosomal aberrations in human lym- Frome, E.L., D. Cragle, and R. McLain. 1990. Poisson regression analysis phocytes analysed by FISH; applicability to biological dosimetry. Int J of the mortality among a cohort of World War II nuclear industry work- Radiat Biol 75:1215-1222. ers. Radiat Res 123:138-152. Finnon, R., J. Moody, E. Meijne, J. Haines, D. Clark, A. Edwards, R. Cox, Frome, E.L., D.L. Cragle, J.P. Watkins, S. Wing, C.M. Shy, W.G. and A. Silver. 2002. A major breakpoint cluster domain in murine radia- Tankersley, and C.M. West. 1997. A mortality study of employees of tion-induced acute myeloid leukemia. Mol Carcinogen 34:64-71. the nuclear industry in Oak Ridge, Tennessee. Radiat Res 148:64-80. Finucane, D.M., E. Bossy-Wetzel, N.J. Waterhouse, T.G. Cotter, and D.R. Fry, R.J., J.B. Storer, and F.J. Burns. 1986. Radiation induction of cancer of Green. 1999. Bax-induced caspase activation and apoptosis via cyto- the skin. Brit J Radiol 19(Suppl):58-60. chrome c release from mitochondria is inhibitable by Bcl-xL. J Biol Fu, Y.P., J.C. Yu, T.C. Cheng, M.A. Lou, G.C. Hsu, C.Y. Wu, S.T. Chen, Chem 274:2225-2233. H.S. Wu, P.E. Wu, and C.Y. Shen. 2003. Breast cancer risk associated Fishel, R., and R.D. Kolodner. 1995. Identification of mismatch repair genes with genotypic polymorphism of the nonhomologous end-joining genes: and their role in the development of cancer. Curr Opin Genet Dev 5:382- a multigenic study on cancer susceptibility. Cancer Res 63:2440-2446. 395. Fuchs, C.S., and R.J. Mayer. 1995. Gastric carcinoma. N Engl J Med 333:32-41.

OCR for page 337
REFERENCES 347 Fujiwara, S., R. Sposto, H. Ezaki, S. Akiba, K. Neriishi, K. Kodama, Y. Gilbert, E.S., D.L. Cragle, and L.D. Wiggs. 1993a. Updated analyses of Hosoda, and K. Shimaoka. 1992. Hyperparathyroidism among atomic combined mortality data for workers at the Hanford Site, Oak Ridge bomb survivors in Hiroshima. Radiat Res 130:372-378. National Laboratory, and Rocky Flats Weapons Plant. Radiat Res Fujiwara, S., S. Kusumi, J. Cologne, M. Akahoshi, K. Kodama, and H. 136:408-421. Yoshizawa. 2000. Prevalence of anti-hepatitis C virus antibody and Gilbert, E.S., E. Omohundro, J. Buchanna, and N. Holter. 1993b. Mortality chronic liver disease among atomic bomb survivors. Radiat Res 154: of workers at the Hanford Site: 1945-1986. Health Phys 64:577-590. 12-19. Gilbert, E.S., N.A. Koshurnikova, M. Sokolnikov, V.F. Khokhryakov, S. Fukasawa, K., F. Wiener, G.F. Vande Woude, and S. Mai. 1997. Genomic Miller, D.L. Preston, S.A. Romanov, N.S. Shilnikova, K.G. Suslova, instability and apoptosis are frequent in p53 deficient young mice. and V.V. Vostrotin. 2000. Liver cancers in Mayak workers. Radiat Res Oncogene 15:1295-1302. 154:246-252. Furre, T., M. Koritzinsky, D.R. Olsen, and E.O. Pettersen. 1999. Inverse Gilbert, E.S., M. Stovall, M. Gospodarowicz, F.E. Van Leeuwen, M. dose-rate effect due to pre-mitotic accumulation during continuous low Andersson, B. Glimelius, T. Joensuu, C.F. Lynch, R.E. Curtis, E. dose-rate irradiation of cervix carcinoma cells. Int J Radiat Biol 75: Holowaty, H. Storm, E. Pukkala, M.B. van’t Veer, J.F. Fraumeni, J.D. 699-707. Boice Jr., E.A. Clarke, and L.B. Travis. 2003. Lung cancer after treat- Gajewski, E., G. Rao, Z. Nackerdien, and M. Dizdaroglu. 1990. Modifica- ment for Hodgkin’s disease: focus on radiation effects. Radiat Res tion of DNA bases in mammalian chromatin by radiation-generated free 159:161-173. radicals. Biochemistry 29:7876-7882. Gilman, E.G., A.M. Stewart, E.G. Knox, and G.W. Kneale. 1989. Trends in Game, J.C., G.W. Birrell, J.A. Brown, T. Shibata, C. Baccari, A.M. Chu, obstetric radiography, 1939-81. J Radiol Prot 9:93-101. M.S. Williamson, and J.M. Brown. 2003. Use of a genome-wide ap- Gimm, O., H. Dziema, J. Brown, C. Hoang-Vu, R. Hinze, H. Dralle, L.M. proach to identify new genes that control resistance of Saccharomyces Mulligan, and C. Eng. 2001. Over-representation of a germline variant cerevisiae to ionizing radiation. Radiat Res 160:14-24. in the gene encoding RET co-receptor GFRalpha-1 but not GFRalpha-2 Gardner M.J., A.J. Hall, S. Downes, and J.D. Terrell. 1987. Follow up study or GFRalpha-3 in cases with sporadic medullary thyroid carcinoma. of children born to mothers resident in Seascale, West Cumbria (birth Oncogene 20:2161-2170. cohort). Brit Med J 295:822-827. Gisselsson, D., L. Pettersson, M. Hoglund, M. Heidenblad, L. Gorunova, J. Gardner, M.J., A.J. Hall, M.P. Snee, S. Downes, C.A. Powell, and J.D. Wiegant, F. Mertens, P. Dal Cin, F. Mitelman, and N. Mandahl. 2000. Terrell. 1990a. Methods and basic data of case-control study of leu- Chromosomal breakage-fusion-bridge events cause genetic intratumor kaemia and lymphoma among young people near Sellafield nuclear heterogeneity. Proc Natl Acad Sci USA 97:5357-5362. plant in West Cumbria. Brit Med J 300:429-434. Goldman, M.B., F. Maloof, R.R. Monson, A. Aschengrau, D. Cooper, and Gardner, M.J., M.P. Snee, A.J. Hall, C.A. Powell, S. Downes, and J.D. E. Ridgway. 1988. Radioactive iodine therapy and breast cancer: a fol- Terrell. 1990b. Results of case-control study of leukaemia and lym- low-up study of hyperthyroid women. Am J Epidemiol 127:969-980. phoma among young people near Sellafield nuclear plant in West Goldstone, A.R., P. Quirke, and M.F. Dixon. 1996. Helicobacter pylori Cumbria. Brit Med J 300:423-429. infection and gastric cancer. J Pathol 179:129-137. Gellon, L., R. Barbey, P. Auffret van der Kemp, D. Thomas, and S. Boiteux. Goode, E.L., C.M. Ulrich, and J.D. Potter. 2002. Polymorphisms in DNA 2001. Synergism between base excision repair, mediated by the DNA repair genes and associations with cancer risk. Cancer Epidemiol glycosylases Ntg1 and Ntg2, and nucleotide excision repair in the re- Biomarkers Prev 11:1513-1530. moval of oxidatively damaged DNA bases in Saccharomyces cerevisiae. Goodhead, D.T. 1994. Initial events in the cellular effects of ionizing radia- Mol Genet Genomics 265:1087-1096. tions: clustered damage in DNA. Int J Radiat Biol 65:7-17. Geoffroy-Perez, B., N. Janin, K. Ossian, A. Lauge, M.F. Croquette, C. Gorman, M.A., S. Morera, D.G. Rothwell, E. de La Fortelle, C.D. Mol, J.A. Griscelli, M. Debre, B. Bressac-de-Paillerets, A. Aurias, D. Stoppa- Tainer, I.D. Hickson, and P.S. Freemont. 1997. The crystal structure of Lyonnet, and N. Andrieu. 2001. Cancer risk in heterozygotes for ataxia- the human DNA repair endonuclease HAP1 suggests the recognition of telangiectasia. Int J Cancer 93:288-293. extra-helical deoxyribose at DNA abasic sites. EMBO J 16:6548-6558. Gibbs, M., A. Collick, R.G. Kelly, and A.J. Jeffreys. 1993. A tetranucleotide Gowen, L.C., A.V. Avrutskaya, A.M. Latour, B.H. Koller, and S.A. Leadon. repeat mouse minisatellite displaying substantial somatic instability 1998. BRCA1 required for transcription-coupled repair of oxidative during early preimplantation development. Genomics 17:121-128. DNA damage. Science 281:1009-1012. Gibbs, R.A., J. Camakaris, G.S. Hodgson, and R.F. Martin. 1987. Molecu- Greaves, M.F., and J. Wiemels. 2003. Origins of chromosome transloca- lar characterization of 125I decay and X-ray-induced HPRT mutants in tions in childhood leukaemia. Nat Rev Cancer 3:639-649. CHO cells. Int J Radiat Biol Re 51:193-199. Green, P.M., S. Saad, C.M. Lewis, and F. Giannelli. 1999. Mutation rates in Gilbert, E.S. 1989. Issues in analysing the effects of occupational exposure humans. I. Overall and sex-specific rates obtained from a population to low levels of radiation. Stat Med 8:173-187. study of hemophilia B. Am J Hum Genet 65:1572-1579. Gilbert, E.S. 1991. Chapter 3: Late somatic effects. In Health Effects Mod- Greenberg, E.R., B. Rosner, C. Hennekens, R. Rinsky, and T. Colton. 1985. els for Nuclear Power Plant Accident Consequence Analysis. Modifica- An investigation of bias in a study of nuclear shipyard workers. Am J tions of Models Resulting from Recent Reports on Health Effects of Epidemiol 121:301-308. Ionizing Radiation, Low LET Radiation, Part II: Scientific Bases for Greenblatt, M.S., W.P. Bennett, M. Hollstein, and C.C. Harris. 1994. Muta- Health Effects Models, S. Abrahamson and others, eds. NUREG/CR- tions in the p53 tumor suppressor gene: clues to cancer etiology and 4214, Rev. 1, Part II, Addendum 1, LMF-132. molecular pathogenesis. Cancer Res 54:4855-4878. Gilbert, E.S. 1998. Accounting for errors in dose estimates used in studies Greider, C.W. 1996. Telomere length regulation. Annu Rev Biochem of workers exposed to external radiation. Health Phys 74:22-29. 65:337-365. Gilbert, E.S., and J.J. Fix. 1995. Accounting for bias in dose estimates in Greinert, R., E. Detzler, and D. Harder. 2000. The kinetics of postirradia- analyses of data from nuclear worker mortality studies. Health Phys tion chromatin restitution as revealed by chromosome aberrations de- 68:650-660. tected by premature chromosome condensation and fluorescence in situ Gilbert, E.S., S.A. Fry, L.D. Wiggs, G.L. Voelz, D.L. Cragle, and G.R. hybridization. Radiat Res 154:87-93. Petersen. 1989. Analyses of combined mortality data on workers at the Gribbin, M.A., J.L. Weeks, and G.R. Howe. 1993. Cancer mortality (1956- Hanford Site, Oak Ridge National Laboratory, and Rocky Flats Nuclear 1985) among male employees of Atomic Energy of Canada Limited Weapons Plant. Radiat Res 120:19-35. with respect to occupational exposure to external low-linear-energy- transfer ionizing radiation. Radiat Res 133:375-380.

OCR for page 337
362 REFERENCES Prisyazhiuk, A., O.A. Pjatak, V.A. Buzanov, G.K. Reeves, and V. Beral. Richardson, D.B., and S. Wing. 1999a. Greater sensitivity to ionizing radia- 1991. Cancer in the Ukraine, post-Chernobyl. Lancet 338:1334-1335. tion at older age: follow-up of workers at Oak Ridge National Labora- Prisyazhniuk, A., V. Gristchenko, V. Zakordonets, N. Fouzik, Y. Slipeniuk, tory through 1990. Int J Epidemiol 28:428-436. and I. Ryzhak. 1995. The time trends of cancer incidence in the most Richardson, D.B., and S. Wing. 1999b. Radiation and mortality of workers contaminated regions of the Ukraine before and after the Chernobyl at Oak Ridge National Laboratory: positive associations for doses re- accident. Radiat Environ Biophys 34:3-6. ceived at older ages. Environ Health Persp 107:649-656. Prisyazhniuk, A., Z. Fedorenko, A. Okaenov, V. Ivanov, V. Starinsky, V. Richardson, S., C. Monfort, M. Green, G. Draper, and C. Muirhead. 1995. Gristchenko, and L. Remennik. 1996. Epidemiology of cancer in popu- Spatial variation of natural radiation and childhood leukaemia incidence lations living in contaminated territories of Ukraine, Belarus, Russia in Great Britain. Stat Med 14:2487-2501. after the Chernobyl accident. Pp. 909-921 in The Radiological Conse- Richter, H.E., H.D. Lohrer, L. Hieber, A.M. Kellerer, E. Lengfelder, and M. quences of the Chernobyl Accident. Brussels: European Commission, Bauchinger. 1999. Microsatellite instability and loss of heterozygosity EUR 16544. in radiation-associated thyroid carcinomas of Belarussian children and Prysyazhnyuk A.Y., L.O. Gulak, V.G. Gristchyenko, and Z.P. Fedorenko. adults. Carcinogenesis 20:2247-2252. 2002. Cancer incidence in Ukraine after the Chernobyl accident. In Rigaud, O., A. Laquerbe, and E. Moustacchi. 1995. DNA sequence analysis Chernobyl: Message for the 21st Century. Proceedings of the Sixth of HPRT-mutants induced in human lymphoblastoid cells adapted to Chernobyl Sasakawa Medical Cooperation Symposium. New York: ionizing radiation. Radiat Res 144:181-189. Elsevier. Rinsky, R.A., R.D. Zumwalde, R.J. Waxweiler, W.E. Murray Jr., P.J. Puck, T.T., and C.A. Waldren. 1987. Mutation in mammalian cells: theory Bierbaum, P.J. Landrigan, M. Terpilak, and C. Cox. 1981. Cancer mor- and implications. Somat Cell Mol Genet 13:405-409. tality at a naval nuclear shipyard. Lancet 1:231-235. Puck, T.T., R. Johnson, and S. Rasumussen. 1997. A system for mutation Rinsky, R.A., J.M. Melius, R.W. Hornung, R.D. Zumwalde, R.J. measurement in mammalian cells: application to gamma-irradiation. Waxweiler, P.J. Landrigan, P.J. Bierbaum, and W.E. Murray Jr. 1988. Proc Natl Acad Sci USA 94:1218-1223. Case-control study of lung cancer in civilian employees at the Ports- Rabbitts, T.H. 1994. Chromosomal translocations in human cancer. Nature mouth Naval Shipyard, Kittery, Maine. Am J Epidemiol 127:55-64. 372:143-149. Ritz, B. 1999. Radiation exposure and cancer mortality in uranium process- Rabes, H.M., E.P. Demidchik, J.D. Sidorow, E. Lengfelder, C. Beimfohr, ing workers. Epidemiology 10:531-538. D. Hoelzel, and S. Klugbauer. 2000. Pattern of radiation-induced RET Ritz, B., H. Morgenstern, J. Froines, and B.B. Young. 1999a. Effects of and NTRK1 rearrangements in 191 post-Chernobyl papillary thyroid exposure to external ionizing radiation on cancer mortality in nuclear carcinomas: biological, phenotypic, and clinical implications. Clin Can- workers monitored for radiation at Rocketdyne/Atomics International. cer Res 6:1093-1103. Am J Ind Med 35:21-31. Rafii, S., P. O’Regan, G. Xinarianos, I. Azmy, T. Stephenson, M. Reed, M. Ritz, B., H. Morgenstern, and J. Moncau. 1999b. Age at exposure modifies Meuth, J. Thacker, and A. Cox. 2002. A potential role for the XRCC2 the effects of low-level ionizing radiation on cancer mortality in an oc- R188H polymorphic site in DNA-damage repair and breast cancer. Hum cupational cohort. Epidemiology 10:135-140. Mol Genet 11:1433-1438. Ritz, B., H. Morgenstern, D. Crawford-Brown, and B. Young. 2000. The Rahu, M., M. Tekkel, T. Veidebaum, E. Pukkala, T. Hakulinen, A. Auvinen, effects of internal radiation exposure on cancer mortality in nuclear T. Rytomaa, P.D. Inskip, and J.D. Boice. 1997. The Estonian study of workers at Rocketdyne/Atomics International. Environ Health Persp Chernobyl cleanup workers: II. Incidence of cancer and mortality. 108:743-751. Radiat Res 147:653-657. Roberts, S.A., A.R. Spreadborough, B. Bulman, J.B. Barber, D.G. Evans, Rallison, M.L., B.M. Dobyns, F.R. Keating Jr., J.E. Rall, and F.H. Tyler. and D. Scott. 1999. Heritability of cellular radiosensitivity: a marker of 1975. Thyroid nodularity in children. J Am Med Assoc 233:1069-1072. low-penetrance predisposition genes in breast cancer? Am J Hum Genet Ramsay, C.N., P.M. Ellis, and H. Zealley. 1991. Down’s syndrome in the 65:784-794. Lothian region of Scotland—1978 to 1989. Biomed Pharmacother Robison, L.L., and A. Mertens. 1993. Second tumors after treatment of 45:267-272. childhood malignancies. Hematol Oncol Clin North Am 7:401-415. Ranier, S., L.A. Johnson, C.J. Dobry, A.J. Ping, P.E. Grundy, and A.P. Robson, T.A., H. Lohrer, J.R. Bailie, D.G. Hirst, M.C. Joiner, and J.E. Feinberg. 1993. Relaxation of imprinted genes in human cancer. Nature Arrand. 1997. Gene regulation by low-dose ionizing radiation in a nor- 362:749-751. mal human lung epithelial cell line. Biochem Soc Trans 25:335-342. Redpath, J.L., and R.J. Antoniono. 1998. Induction of an adaptive response Robson, T., M.C. Joiner, G.D. Wilson, W. McCullough, M.E. Price, I. Lo- against spontaneous neoplastic transformation in vitro by low-dose gan, H. Jones, S.R. McKeown, and D.G. Hirst. 1999. A novel human gamma radiation. Radiat Res 149:517-520. stress response-related gene with a potential role in induced radioresis- Redpath, J.L., D. Liang, T.H. Taylor, C. Christie, and E. Elmore. 2001. The tance. Radiat Res 152:451-461. shape of the dose-response curve for radiation-induced neoplastic trans- Robson, T., M.E. Price, M.L. Moore, M.C. Joiner, V.J. McKelvey-Martin, formation in vitro: evidence for an adaptive response against neoplastic S.R. McKeown, and D.G. Hirst. 2000. Increased repair and cell survival transformation at low doses of low-LET radiation. Radiat Res 156: in cells treated with DIR1 antisense oligonucleotides: implications for 700-707. induced radioresistance. Int J Radiat Biol 76:617-623. Remennik, L.V., V.V. Starinsky, V.I. Chissov, V.D. Mokina, and M.M. Roderick, T.H. 1963. The response of twenty-seven inbred strains of mice Rubtsova. 1996. Malignant neoplasm of thyroid in children and in adults to daily doses of whole body x-irradiation. Radiat Res 20:613-614. on the territories suffered from the Chernobyl accident. Pp. 519-520 in Roesch, W.C., Radiation Effects Research Foundation, and National Acad- International Conference One Decade After Chernobyl: Summing up emy of Sciences (U.S.). 1987. US-Japan joint reassessment of atomic the Consequences of the Accident, Book of Extended Synopses. Vienna: bomb radiation dosimetry in Hiroshima and Nagasaki. Minami-ku, International Atomic Energy Agency. Hiroshima: Radiation Effects Research Foundation. Ribeiro, R.C., F. Sandrini, B. Figueiredo, G.P. Zambetti, E. Michalkiewicz, Rogel A, N. Carré, E. Amoros, M. Bonnet-Belfais, M. Goldberg, E. A.R. Lafferty, L. DeLacerda, M. Rabin, C. Cadwell, G. Sampaio, I. Cat, Imbernon, T. Calvez, and C. Hill. 2005. Mortality of workers exposed C.A. Stratakis, and R. Sandrini. 2001. An inherited p53 mutation that to ionizing radiation at the French National Electricity Company. Am J contributes in a tissue-specific manner to pediatric adrenal cortical car- Ind Med 47:72–82. cinoma. Proc Natl Acad Sci USA 98:9330-9335. Richardson, D.B., and S. Wing. 1998. Methods for investigating age differ- ences in the effects of prolonged exposures. Am J Ind Med 33:123-130.

OCR for page 337
REFERENCES 363 Roman, E., A. Watson, V. Beral, S. Buckle, D. Bull, K. Baker, H. Ryder, Rosenquist, T.A., E. Zaika, A.S. Fernandes, D.O. Zharkov, H. Miller, and and C. Barton. 1993. Case-control study of leukaemia and non- A.P. Grollman. 2003. The novel DNA glycosylase, NEIL1, protects Hodgkin’s lymphoma among children aged 0-4 years living in west mammalian cells from radiation-mediated cell death. DNA Repair Berkshire and north Hampshire health districts. Brit Med J 306: 2:581-591. 615-621. Rossi, H.H., and M. Zaider. 1996. Microdosimetry and Its Applications. Roman, E., P. Doyle, N. Maconochie, G. Davies, P.G. Smith, and V. Beral. Berlin: Springer-Verlag. 1999. Cancer in children of nuclear industry employees: report on chil- Roth, S.Y. 1996. Something about silencing. Nat Genet 14:3-4. dren aged under 25 years from nuclear industry family study. Brit Med Rothkamm, K., and M. Lobrich. 2003. From the cover: evidence for a lack J 318:1443-1450. of DNA double-strand break repair in human cells exposed to very low Romanenko, A., L. Morell-Quadreny, V. Nepomnyaschy, A. Vozianov, and x-ray doses. Proc Natl Acad Sci USA 100:5057-5062. A. Llombart-Bosch. 2000. Pathology and proliferative activity of renal- Rothkamm, K., I. Kruger, L.H. Thompson, and M.Lobrich. 2003. Pathways cell carcinomas (RCCS) and renal oncocytomas in patients with differ- of DNA double-strand break repair during the mammalian cell cycle. ent radiation exposure after the Chernobyl accident in Ukraine. Int J Mol Cell Biol 23:5706-5715. Cancer 87:880-883. Rubino, C., E. Adjadj, S. Guerin, C. Guibout, A. Shamsaldin, M.G. Dondon, Romanenko, A., K. Morimura, M. Wei, W. Zaparin, A. Vozianov, and S. D. Valteau-Couanet, O. Hartmann, M. Hawkins, and F. de Vathaire. Fukushima. 2002. DNA damage repair in bladder urothelium after the 2003. Long-term risk of second malignant neoplasms after neuroblas- Chernobyl accident in Ukraine. J Urol 168:973-977. toma in childhood: role of treatment. Int J Cancer 107:791-796. Romanenko, A., K. Morimura, H. Wanibuchi, M. Wei, W. Zaparin, W. Rudolph, K.L., M. Millard, M.W. Bosenberg, and R.A. DePinho. 2001. Vinnichenko, A. Kinoshita, A. Vozianov, and S. Fukushima. 2003. Uri- Telomere dysfunction and evolution of intestinal carcinoma in mice and nary bladder lesions induced by persistent chronic low-dose ionizing humans. Nat Genet 28:155-159. radiation. Cancer Sci 94:328-333. Russell, L.B. 1999. Significance of the perigametic interval as a major Romney, C.A., J.D. Paulauskis, H. Nagasawa, and J.B. Little. 2001. Mul- source of spontaneous mutations that result in mosaics. Environ Mol tiple manifestations of x-ray-induced genomic instability in Chinese Mutagen 34:16-23. hamster ovary (CHO) cells. Mol Carcinog 32:118-127. Russell, L.B., and W.L. Russell. 1996. Spontaneous mutations recovered as Ron, E. 1998. Ionizing radiation and cancer risk: evidence from epidemiol- mosaics in the mouse specific-locus test. Proc Natl Acad Sci USA ogy. Radiat Res 150:S30-S41. 93:13072-13077. Ron, E., and B. Modan. 1984. Thyroid and other neoplasms following child- Russell, W.L. 1965. Studies in mammalian radiation genetics. Nucleonics hood scalp irradiation. Radiation Carcinogenesis: Epidemiology and 23:53-56, 62. Biological Significance, J.D. Boice and J.F Fraumeni, eds. New York: Russell, W.L. 1968. Recent studies on the genetic effects of radiation in Raven Press. mice. Pediatrics 41:223-230. Ron, E., B. Modan, J.D. Boice, E. Alfandary, M. Stovall, A. Chetrit, and L. Russell, W.L., L.B. Russell, and E.M. Kelly. 1958. Radiation dose rate and Katz. 1988a. Tumors of the brain and nervous system after radiotherapy mutation frequency. Science 128:1546-1550. in childhood. N Engl J Med 319:1033-1039. Russell, W.L., L.B. Russell, and M.B. Cupp. 1959. Dependence of muta- Ron, E., B. Modan, and J.D. Boice Jr. 1988b. Mortality after radiotherapy tion frequency on radiation dose rate in female mice. Proc Natl Acad Sci for ringworm of the scalp. Am J Epidemiol 127:713-725. USA 45:18-23. Ron, E., B. Modan, D. Preston, E. Alfandary, M. Stovall, and J.D. Boice Jr. Russell, W.L., J.W. Bangham, and L.B. Russell. 1998. Differential response 1989. Thyroid neoplasia following low-dose radiation in childhood. of mouse male germ-cell stages to radiation-induced specific-locus and Radiat Res 120:516-531. dominant mutations. Genetics 148:1567-1578. Ron, E., B. Modan, D. Preston, S. Hamburger, and M. Stovall. 1994. Mor- Rutledge, J.C., K.T. Cain, L.A. Hughes, P.W. Braden, and W.M. Generoso. tality following radiation treatment for infertility of hormonal origin or 1986. Difference between two hybrid stocks of mice in the incidence of amenorrhoea. Int J Epidemiol 23:1165-1173. congenital abnormalities following x-ray exposure of stem-cell sper- Ron, E., J.H. Lubin, R.E. Shore, K. Mabuchi, B. Modan, L. Pottern, A.B. matogonia. Mutat Res 163:299-302. Schneider, M.A. Tucker, and J.D. Boice. 1995a. Thyroid cancer after Ryberg, M., M. Lundell, B. Nilsson, and F. Pettersson. 1990. Malignant exposure to external radiation: a pooled analysis of seven studies. Radiat disease after radiation treatment of benign gynaecological disorders. A Res 141:259-277. study of a cohort of metropathia patients. Acta Oncol 29:563-567. Ron, E., F.L. Wong, and K. Mabuchi. 1995b. Incidence of benign gas- Rydberg, B. 1996. Clusters of DNA damage induced by ionizing radiation: trointestinal tumors among atomic bomb survivors. Am J Epidemiol formation of short DNA fragments. 2. Experimental detection. Radiat 142:68-75. Res 145:200-209. Ron, E., M.M. Doody, D.V. Becker, A.B. Brill, R.E. Curtis, M.B. Goldman, Sabatier, L., B. Dutrillaux, and M.B. Martin. 1992. Chromosomal instabil- B.S. Harris 3rd, D.A. Hoffman, W.M. McConahey, H.R. Maxon, S. ity. Nature 357:548. Preston-Martin, M.E. Warshauer, F.L. Wong, and J.D. Boice Jr. 1998a. Sabatier, L., M. Ricoul, G. Pottier, N. Mathieu, and J.P. Murnane. 2005. Cancer mortality following treatment for adult hyperthyroidism. Coop- The loss of a single telomere can result in instability of multiple chro- erative Thyrotoxicosis Therapy Follow-Up Study Group. J Am Med mosomes in a human tumor cell line. Mol Can Res 3:139-150. Assoc 280:347-355. Sacher, G.A. 1955. A comparative analysis of radiation lethality in mam- Ron, E., D.L. Preston, M. Kishikawa, T. Kobuke, M. Iseki, S. Tokuoka, M. mals exposed at constant average intensity for the duration of life. J Natl Tokunaga, and K. Mabuchi. 1998b. Skin tumor risk among atomic- Cancer Inst 15:1125-1144. bomb survivors in Japan. Cancer Cause Control 9:393-401. Sachs, R.K., A.M. Chen, and D.J. Brenner. 1997. Review: proximity effects Rooney, C., V. Beral, N. Maconochie, P. Fraser, and G. Davies. 1993. Case- in the production of chromosome aberrations by ionizing radiation. Int J control study of prostatic cancer in employees of the United Kingdom Radiat Biol 71:1-19. Atomic Energy Authority. Brit Med J 307:1391-1397. Sadamoto, S., S. Suzuki, K. Kamiya, R. Kominami, K. Dohi, and O. Niwa. Roots, R., and S. Okada. 1972. Protection of DNA molecules of cultured 1994. Radiation induction of germline mutation at a hypervariable mammalian cells from radiation-induced single-strand scissions by vari- mouse minisatellite locus. Int J Radiat Biol 65:549-557. ous alcohols and SH compounds. Int J Radiat Biol Res 21:329-342. Sadekova, S., S. Lehnert, and T.Y. Chow. 1997. Induction of PBP74/ Rosemann, M., M. Lintrop, J. Favor, and M.J. Atkinson. 2002. Bone tum- mortalin/Grp75, a member of the hsp70 family, by low doses of ioniz- origenesis induced by alpha-particle radiation: mapping of genetic loci ing radiation: a possible role in induced radioresistance. Int J Radiat influencing predisposition in mice. Radiat Res 157:426-434. Biol 72:653-660.

OCR for page 337
364 REFERENCES Sadetzki, S., P. Flint-Richter, T. Ben-Tal, and D. Nass. 2002. Radiation- Sasaki, M.S., K. Kobayashi, K. Hieda, Y. Yamada, Y. Ejima, H. Maezawa, induced meningioma: a descriptive study of 253 cases. J Neurosurg Y. Furusawa, T. Ito, and S. Okada. 1989. Induction of chromosome 97:1078-1082. aberrations in human lymphocytes by monochromatic x-rays of quan- Sadetzki, S., A. Chetrit, L. Freedman, M. Stovall, B. Modan, and tum energy between 4.8 and 14.6 keV. Int J Radiat Biol 56:975-988. I. Novikov. 2005. Long-term follow-up for brain tumor development Satoh, C., and M. Kodaira. 1996. Effects of radiation on children. Nature after childhood exposure to ionizing radiation for tinea capitis. Radiat 383:226. Res 163:424-432. Satoh, C., N. Takahashi, J. Asakawa, M. Kodaira, R. Kuick, S.M. Hanash, Saenger, E.L., G.E. Thoma, and E.A. Tompkins. 1968. Incidence of leuke- and J.V. Neel. 1996. Genetic analysis of children of atomic bomb survi- mia following treatment of hyperthyroidism. Preliminary report of the vors. Environ Health Persp 104(Suppl 3):511-519. Cooperative Thyrotoxicosis Therapy Follow-up Study. J Am Med Assoc Saul, R.L., and B.N. Ames. 1986. Background levels of DNA damage in the 205:855-862. population. Basic Life Sci 38:529-535. Safa, A.M., O.P. Schumacher, and A. Rodriguez-Antunez. 1975. Long-term Savage, J.R. 1996. Insight into sites. Mutat Res 366:81-95. follow-up results in children and adolescents treated with radioactive Savitsky, K., S. Sfez, D.A. Tagle, Y. Ziv, A. Sartiel, F.S. Collins, Y. Shiloh, iodine (131I) for hyperthyroidism. N Engl J Med 292:167-171. and G. Rotman. 1995. The complete sequence of the coding region of Sagan, L.A. 1987. Health Physics, Vol. 52: Special Issue on Radiation the ATM gene reveals similarity to cell cycle regulators in different Hormesis. New York: Pergamon Press. species. Hum Mol Genet 4:2025-2032. Saito, Y., Y. Ochiai, Y. Kodama, Y. Tamura, T. Togashi, H. Kosugi-Okano, Sawant, S.G., G. Randers-Pehrson, C.R. Geard, D.J. Brenner, and E.J. Hall. T. Miyazawa, Y. Wakabayashi, K. Hatakeyama, S. Wakana, O. Niwa, 2001a. The bystander effect in radiation oncogenesis: I. Transformation and R. Kominami. 2001. Genetic loci controlling susceptibility to in C3H 10T1/2 cells in vitro can be initiated in the unirradiated neigh- gamma-ray-induced thymic lymphoma. Oncogene 20:5243-5247. bors of irradiated cells. Radiat Res 155:397-401. Sankaranarayanan, K. 1976. Evaluation and re-evaluation of genetic radia- Sawant, S.G., G. Randers-Pehrson, N.F. Metting, and E.J. Hall. 2001b. tion hazards in man. III. Other relevant data and risk assessment. Mutat Adaptive response and the bystander effect induced by radiation in C3H Res 35:387-414. 10T(1/2) cells in culture. Radiat Res 156:177-180. Sankaranarayanan, K. 1991. Ionizing radiation and genetic risks. III. Nature Sawant, S.G., W. Zheng, K.M. Hopkins, G. Randers-Pehrson, H.B. of spontaneous and radiation-induced mutations in mammalian in vitro Lieberman, and E.J. Hall. 2002. The radiation-induced bystander effect systems and mechanisms of induction of mutations by radiation. Mutat for clonogenic survival. Radiat Res 157:361-364. Res 258:75-97. Schappi-Buchi, C. 1994. On the genetic background of the adaptive re- Sankaranarayanan, K. 1998. Ionizing radiation and genetic risks. IX. Esti- sponse to x-rays in Drosophila melanogaster. Int J Radiat Biol 65: mates of the frequencies of Mendelian diseases and spontaneous muta- 427-435. tion rates in human populations: a 1998 perspective. Mutat Res 411: Schiestl, R.H., F. Khogali, and N. Carls. 1994. Reversion of the mouse 129-178. pink-eyed unstable mutation induced by low doses of x-rays. Science Sankaranarayanan, K. 1999. Ionizing radiation and genetic risks. X. The 266:1573-1576. potential “disease phenotypes” of radiation-induced genetic damage in Schinzel, A. 1988. Microdeletion syndromes, balanced translocations, and humans: perspectives from human molecular biology and radiation ge- gene mapping. J Med Genet 25:454-462. netics. Mutat Res 429:45-83. Schmickel, R.D. 1986. Contiguous gene syndromes: a component of recog- Sankaranarayanan, K., and R. Chakraborty. 2000a. Ionizing radiation and nizable syndromes. J Pediatr 109:231-241. genetic risks. XIII. Summary and synthesis of papers VI to XII and Schmid, E., D. Regulla, S. Guldbakke, D. Schlegel, and M. Bauchinger. estimates of genetic risks in the year 2000. Mutat Res 453:183-197. 2000. The effectiveness of monoenergetic neutrons at 565 keV in pro- Sankaranarayanan, K., and R. Chakraborty. 2000b. Ionizing radiation and ducing dicentric chromosomes in human lymphocytes at low doses. genetic risks. XII. The concept of “potential recoverability correction Radiat Res 154:307-312. factor” (PRCF) and its use for predicting the risk of radiation-inducible Schmid, E., D. Regulla, H.M. Kramer, and D. Harder. 2002. The effect of genetic disease in human live births. Mutat Res 453:129-181. 29 kV x rays on the dose response of chromosome aberrations in human Sankaranarayanan, K., A.V. Duyn, M.J. Loos, and A.T. Natarajan. 1989. lymphocytes. Radiat Res 158: 771-777. Adaptive response of human lymphocytes to low-level radiation from Schmidt-Kastner, P.K., K. Jardine, M. Cormier, and M.W. McBurney. 1998. radioisotopes or x-rays. Mutat Res 211:7-12. Absence of p53-dependent cell cycle regulation in pluripotent mouse Sankaranarayanan, K., N. Yasuda, R. Chakraborty, G. Tusnady, and A.E. cell lines. Oncogene 16:3003-3011. Czeizel. 1994. Ionizing radiation and genetic risks. V. Multifactorial Schmutte, C., and R. Fishel. 1999. Genomic instability: first step to carcino- diseases: a review of epidemiological and genetic aspects of congenital genesis. Anticancer Res 19:4665-4696. abnormalities in man and of models on maintenance of quantitative traits Schneider, A.B., E. Shore-Freedman, U.Y. Ryo, C. Bekerman, M. Favus, in populations. Mutat Res 317:1-23. and S. Pinsky. 1985. Radiation-induced tumors of the head and neck Sankaranarayanan, K., R. Chakraborty, and E.A. Boerwinkle. 1999. Ioniz- following childhood irradiation. Prospective studies. Medicine 64:1-15. ing radiation and genetic risks. VI. Chronic multifactorial diseases: a Schneider, A.B., E. Ron, J. Lubin, M. Stovall, and T.C. Gierlowski. 1993. review of epidemiological and genetical aspects of coronary heart dis- Dose-response relationships for radiation-induced thyroid cancer and ease, essential hypertension and diabetes mellitus. Mutat Res 436: thyroid nodules: evidence for the prolonged effects of radiation on the 21-57. thyroid. J Clin Endocrinol Metab 77:362-369. Santos, J., M. Herranz, M. Fernandez, C. Vaquero, P. Lopez, and J. Schollnberger, H., R.E. Mitchel, E.I. Azzam, D.J. Crawford-Brown, and W. Fernandez-Piqueras. 2001. Evidence of a possible epigenetic inactiva- Hofmann. 2002. Explanation of protective effects of low doses of tion mechanism operating on a region of mouse chromosome 19 in gamma-radiation with a mechanistic radiobiological model. Int J Radiat gamma-radiation-induced thymic lymphomas. Oncogene 20:2186- Biol 78:1159-1173. 2189. Schull, W.J., M. Otake, and J.V. Neel. 1981. Genetic effects of the atomic Sasaki, M.S. 1991. Primary damage and fixation of chromosomal DNA as bomb: a reappraisal. Science 213:1220-1227. probed by monochromatic soft x-rays and low-energy neutrons. Pp. 369- Schull, W.J., J.V. Neel, M. Otake, A. Awa, C. Satoh, and H.B. Hamilton. 384 in The Early Effects of Radiation on DNA, E.M. Fielden and P. 1982. Hiroshima and Nagasaki: three and a half decades of genetic O’Neil, eds. NATO ASI Series, Vol. H54. Berlin: Springer-Verlag, screening. Pp. 687-700 in Environmental Mutagens and Carcinogens, Sasaki, M.S. 1995. On the reaction kinetics of the radioadaptive response in T. Sugimura, S. Kondo, and H. Takebe, eds. New York: Alan R. Liss. cultured mouse cells. Int J Radiat Biol 68:281-291.

OCR for page 337
REFERENCES 365 Scott, D. 1980. Molecular mechanisms of chromosome structural changes. Shakhtarin, V.V., A.F. Tsyb, V.F. Stepanenko, M.Y. Orlov, K.J. Kopecky, Pp. 101-113 in Progress in Environmental Mutagenesis, M. Alcevic, ed. and S. Davis. 2003. Iodine deficiency, radiation dose, and the risk of Amsterdam: Elsevier. thyroid cancer among children and adolescents in the Bryansk region of Scott, D., A. Spreadborough, E. Levine, and S.A. Roberts. 1994. Genetic Russia following the Chernobyl power station accident. Int J Epidemiol predisposition in breast cancer. Lancet 344:1444. 32:584-591. Scott, D., J.B. Barber, E.L. Levine, W. Burrill, and S.A. Roberts. 1998. Sharan, S.K., M. Morimatsu, U. Albrecht, D.S. Lim, E. Regel, C. Dinh, A. Radiation-induced micronucleus induction in lymphocytes identifies a Sands, G. Eichele, P. Hasty, and A. Bradley. 1997. Embryonic lethality high frequency of radiosensitive cases among breast cancer patients: a and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. test for predisposition? Brit J Cancer 77:614-620. Nature 386:804-810. Scully, R., J. Chen, R.L. Ochs, K. Keegan, M. Hoekstra, J. Feunteun, and Shellabarger, C.J., D. Chmelevsky, and A.M. Kellerer. 1980. Induction of D.M. Livingston. 1997. Dynamic changes of BRCA1 subnuclear loca- mammary neoplasms in the Sprague-Dawley rat by 430keV neutrons tion and phosphorylation state are initiated by DNA damage. Cell and x-rays. J Natl Cancer Inst 64:821-833. 90:425-435. Shen, M.R., I.M. Jones, and H. Mohrenweiser. 1998. Nonconservative Searle, A.G. 1967. Progress in mammalian radiation genetics. Pp. 469-481 amino acid substitution variants exist at polymorphic frequency in DNA in Proceedings III International Congress of Radiation Research Cortina repair genes in healthy humans. Cancer Res 58:604-608. d’Ampezzo, 1966, Radiation Research, G. Silini, ed. Amsterdam: North Shibata, Y., S. Yamashita, V.B. Masyakin, G.D. Panasyuk, and S. Nagataki. Holland. 2001. 15 years after Chernobyl: new evidence of thyroid cancer. Lancet Searle, A.G. 1976. Use of the Doubling Doses for the Estimation of Genetic 358:1965-1966. Risks. Orsay, France: Euratom. Shields, L.M., W.H. Wiese, B.J. Skipper, B. Charley, and L. Benally. 1992. Searle, A.G., and C. Beechey. 1986. The role of dominant visibles in mu- Navajo birth outcomes in the Shiprock uranium mining area. Health tagenicity testing. Prog Clin Biol Res 209B:511-518. Phys 63:542-551. Seed, T.M., and L.V. Kaspar. 1992. Acquired radioresistance of hemato- Shields, P.G., and C.C. Harris. 2000. Cancer risk and low-penetrance sus- poietic progenitors (granulocyte/monocyte colony-forming units) dur- ceptibility genes in gene-environment interactions. J Clin Oncol ing chronic radiation leukemogenesis. Cancer Res 52:1469-1476. 18:2309-2315. Seed, T.M., and S.M. Meyers. 1993. Chronic radiation-induced alteration Shilnikova, N.S., D.L. Preston, E. Ron, E.S. Gilbert, E.K. Vassilenko, S.A. in hematopoietic repair during preclinical phases of aplastic anemia and Romanov, I.S. Kuznetsova, M.E. Sokolnikov, P.V. Okatenko, V.V. myeloproliferative disease: assessing unscheduled DNA synthesis re- Kreslov, and N.A. Koshurnikova. 2003. Cancer mortality risk among sponses. Cancer Res 53:4518-4527. workers at the Mayak Nuclear Complex. Radiat Res 159:787-798. Seelentag, W.W., W. Panzer, G. Drexler, L. Platz, and F. Pfantner. 1979. A Shiloh, Y. 2001. ATM and ATR: networking cellular responses to DNA Catalogue of Spectra for the Calibration of Dose Meters, GSF-Report damage. Curr Opin Genet Dev 11:71-77. 560. Neuherberg/Munich. Shiloh, Y. 2004. Bridge over broken ends. The cellular response to DNA Selby, P.B. 1998a. Discovery of numerous clusters of spontaneous muta- breaks in health and disease. DNA Repair 3:779-1254. tions in the specific-locus test in mice necessitates major increases in Shimizu, Y., H. Kato, and W.J. Schull. 1990. Studies of the mortality of A- estimates of doubling doses. Genetica 102-103:463-487. bomb survivors. 9. Mortality, 1950-1985: Part 2. Cancer mortality based Selby, P.B. 1998b. Major impacts of gonadal mosaicism on hereditary risk on the recently revised doses (DS86). Radiat Res 121:120-141. estimation, origin of hereditary diseases, and evolution. Genetica 102- Shimizu, Y., H. Kato, W.J. Schull, and K. Mabuchi. 1992. Dose-response 103:445-462. analysis among atomic-bomb survivors exposed to low-level radiation. Selby, P.B., and P.R. Selby. 1977. Gamma-ray-induced dominant muta- Pp. 71-74 in Low Dose Irradiation and Biological Defense Mechanisms, tions that cause skeletal abnormalities in mice. I. Plan, summary of re- T. Sugahara, L. Sagan, and T. Aoyama, eds. Amsterdam: Exerpta sults and discussion. Mutat Res 43:357-375. Medica. Selby, P.B., and P.R. Selby. 1978. Gamma-ray-induced dominant muta- Shimizu, Y., D.A. Pierce, D.L. Preston, and K. Mabuchi. 1999. Studies of tions that cause skeletal abnormalities in mice. III. Description of pre- the mortality of atomic bomb survivors. Report 12, Part II. Noncancer sumed mutations. Mutat Res 50:341-351. mortality: 1950-1990. Radiat Res 152:374-389. Sever, L.E., E.S. Gilbert, N.A. Hessol, and J.M. McIntyre. 1988. A case- Shippey, C.A., M. Layton, and L.M. Secker-Walker. 1990. Leukemia char- control study of congenital malformations and occupational exposure to acterized by multiple sub-clones with unbalanced translocations involv- low-level ionizing radiation. Am J Epidemiol 127:226-242. ing different telomeric segments: case report and review of the litera- Seymour, C.B., and C. Mothersill. 1997. Delayed expression of lethal mu- ture. Gene Chromosome Canc 2:14-17. tations and genomic instability in the progeny of human epithelial cells Shizuma, K., K. Iwatani, H. Hasai, M. Hoshi, T. Oka, and H. Morishima. which survived in a bystander killing environment. Radiat Oncol Investi 1993. Residual 152Eu and 60Co activities induced by neutrons from the 5:106-110. Hiroshima atomic bomb. Health Phys 65:272-282. Seymour, C.B., and C. Mothersill. 2000. Relative contribution of bystander Shore, R.E. 1992. Issues and epidemiological evidence regarding radiation- and targeted cell killing to the low-dose region of the radiation dose- induced thyroid cancer. Radiat Res 131:98-111. response curve. Radiat Res 153:508-511. Shore, R.E. 2001. Radiation-induced skin cancer in humans. Med Pediatr Shadley, J.D., and J.K. Wiencke. 1989. Induction of the adaptive response Oncol 36:549-554. by x-rays is dependent on radiation intensity. Int J Radiat Biol 56: Shore, R.E., and X. Xue. 1999. Comparative thyroid cancer risk of child- 107-118. hood and adult radiation exposure and estimation of lifetime risk. Ra- Shadley, J.D., V. Afzal, and S. Wolff. 1987. Characterization of the adap- diation and Thyroid Cancer. Singapore: World Scientific Publishing. tive response to ionizing radiation induced by low doses of x rays to Shore, R.E., R.E. Albert, M. Reed, N. Harley, and B.S. Pasternack. 1984. human lymphocytes. Radiat Res 111:511-517. Skin cancer incidence among children irradiated for ringworm of the Shafman, T.D., S. Levitz, A.J. Nixon, L.A. Gibans, K.E. Nichols, D.W. scalp. Radiat Res 100:192-204. Bell, C. Ishioka, K.J. Isselbacher, R. Gelman, J. Garber, J.R. Harris, and Shore, R.E., E. Woodard, N. Hildreth, P. Dvoretsky, L. Hempelmann, and D.A. Haber. 2000. Prevalence of germline truncating mutations in ATM B. Pasternack. 1985. Thyroid tumors following thymus irradiation. J in women with a second breast cancer after radiation therapy for a con- Natl Cancer Inst 74:1177-1184. tralateral tumor. Gene Chromosome Canc 27:124-129. Shore, R.E., N. Hildreth, E. Woodard, P. Dvoretsky, L. Hempelmann, and B. Pasternack. 1986. Breast cancer among women given x-ray therapy for acute postpartum mastitis. J Natl Cancer Inst 77:689-696.

OCR for page 337
366 REFERENCES Shore, R.E., N. Hildreth, P. Dvoretsky, E. Andresen, M. Moseson, and B. Smith, L.G., R.C. Miller, M. Richards, D.J. Brenner, and E.J. Hall. 1999. Pasternack. 1993a. Thyroid cancer among persons given x-ray treat- Investigation of hypersensitivity to fractionated low-dose radiation ex- ment in infancy for an enlarged thymus gland. Am J Epidemiol posure. Int J Radiat Oncol 45:187-191. 137:1068-1080. Smith, P.G., and R. Doll. 1981. Mortality from cancer and all causes among Shore, R.E., N. Hildreth, P. Dvoretsky, B. Pasternack, and E. Andresen. British radiologists. Brit J Radiol 54:187-194. 1993b. Benign thyroid adenomas among persons x-irradiated in infancy Smith, P.G., and A.J. Douglas. 1986. Mortality of workers at the Sellafield for enlarged thymus glands. Radiat Res 134:217-223. plant of British Nuclear Fuels. Brit Med J (Clin Res Ed) 293:845-854. Short, S.C., J. Kelly, C.R. Mayes, M. Woodcock, and M.C. Joiner. 2001. Smith, W.M., X.P. Zhou, K. Kurose, X. Gao, F. Latif, T. Kroll, K. Sugano, Low-dose hypersensitivity after fractionated low-dose irradiation in S.A. Cannistra, S.K. Clinton, E.R. Maher, T.W. Prior, and C. Eng. 2001. vitro. Int J Radiat Biol 77:655-664. Opposite association of two PPARG variants with cancer: over- Short, S.C., M. Woodcock, B. Marples, and M.C. Joiner. 2003. Effects of representation of H449H in endometrial carcinoma cases and under- cell cycle phase on low-dose hyper-radiosensitivity. Int J Radiat Biol representation of P12A in renal cell carcinoma cases. Hum Genet 79:99-105. 109:146-151. Sidransky, D. 1996. Is human patched the gatekeeper of common skin can- Sobol, R.W., J.K. Horton, R. Kuhn, H. Gu, R.K. Singhal, R. Prasad, K. cers? Nat Genet 14:7-8. Rajewsky, and S.H. Wilson. 1996. Requirement of mammalian DNA Sielken, R.L., Jr., R.S. Bretzlaff, and D.E. Stevenson. 1994. Incorporating polymerase-beta in base-excision repair. Nature 379:183-186. additional biological phenomena into two-stage cancer models. Prog Sobolev, B., W.F. Heidenreich, I. Kairo, P. Jacob, G. Goulko, and I. Clin Biol Res 387:237-260. Likhtarev. 1997. Thyroid cancer incidence in the Ukraine after the Silver, A., J. Moody, R. Dunford, D. Clark, S. Ganz, R. Bulman, S. Bouffler, Chernobyl accident: comparison with spontaneous incidences. Radiat P. Finnon, E. Meijne, R. Huiskamp, and R. Cox. 1999. Molecular map- Environ Bioph 36:195-199. ping of chromosome 2 deletions in murine radiation-induced AML lo- Sofer, T., J.R. Goldsmith, I. Nusselder, and L. Katz. 1991. Geographical calizes a putative tumor suppressor gene to a 1.0 cM region homologous and temporal trends of childhood leukemia in relation to the nuclear to human chromosome segment 11p11-12. Gene Chromosome Canc plant in the Negev, Israel, 1960-1985. Public Health Rev 19:191-198. 24:95-104. Sonoda, E., M.S. Sasaki, J.M. Buerstedde, O. Bezzubova, A. Shinohara, H. Sinclair, W.K. 1985. Experimental RBE values of high LET radiations at Ogawa, M. Takata, Y. Yamaguchi-Iwai, and S. Takeda. 1998. Rad51- low doses and the implications for quality factor assignment. Radiat deficient vertebrate cells accumulate chromosomal breaks prior to cell Prot Dosim 13:319-326. death. EMBO J 17:598-608. Sinclair, W.K., and R.A. Morton. 1963. Variations in x-ray response during Sont, W.N., J.M. Zielinski, J.P. Ashmore, H. Jiang, D. Krewski, M.E. Fair, the division cycle of partially synchronized Chinese hamster cells in P.R. Band, and E.G. Letourneau. 2001. First analysis of cancer inci- culture. Nature 199:1158-1160. dence and occupational radiation exposure based on the National Dose Singer, M.F. 1982. Highly repeated sequences in mammalian genomes. Int Registry of Canada. Am J Epidemiol 153:309-318. Rev Cytol 76:67-112. Sorahan, T., and P.J. Roberts. 1993. Childhood cancer and paternal expo- Skov, K.A. 1999. Radioresponsiveness at low doses: hyper-radiosensitivity sure to ionizing radiation: preliminary findings from the Oxford Survey and increased radioresistance in mammalian cells. Mutat Res 430:241- of Childhood Cancers. Am J Ind Med 23:343-354. 253. Sorensen, K.J., C.M. Attix, A.T. Christian, A.J. Wyrobek, and J.D. Tucker. Skuse, G.R., and J.W. Ludlow. 1995. Tumour suppressor genes in disease 2002. Adaptive response induction and variation in human lympho- and therapy. Lancet 345:902-906. blastoid cell lines. Mutat Res 519:15-24. Sloan, S.R., E.W. Newcomb, and A. Pellicer. 1990. Neutron radiation can Southwick, G.J., and R.A. Schwartz. 1979. The basal cell nevus syndrome: activate K-ras via a point mutation in codon 146 and induces a different disasters occurring among a series of 36 patients. Cancer 44:2294-2305. spectrum of ras mutations than does gamma radiation. Mol Cell Biol Sposto, R., and D.L. Preston. 1992. Correction for catchment area non- 10:405-408. residency in studies based on tumor-registry data. Hiroshima, Japan: Smida, J., H. Zitzelsberger, A.M. Kellerer, L. Lehmann, G. Minkus, T. Radiation Effects Research Foundation. Negele, F. Spelsberg, L. Hieber, E.P. Demidchik, E. Lengfelder, and M. Sposto, R., D.L. Preston, Y. Shimizu, and K. Mabuchi. 1992. The effect of Bauchinger. 1997. p53 mutations in childhood thyroid tumours from diagnostic misclassification on non-cancer and cancer mortality dose Belarus and in thyroid tumours without radiation history. Int J Cancer response in A-bomb survivors. Biometrics 48:605-617. 73:802-807. Spring, K., F. Ahangari, S.P. Scott, P. Waring, D.M. Purdie, P.C. Chen, K. Smida, J., H. Zitzelsberger, L. Lengfelder, and others. 1999a. Molecular Hourigan, J. Ramsay, P.J. McKinnon, M. Swift, and M.F. Lavin. 2002. genetic analysis of RET rearangements in papillary thyroid carcinomas Mice heterozygous for mutation in ATM, the gene involved in ataxia- from BelaRussian children and adults. Pp. 263-267 in Radiation and telangiectasia, have heightened susceptibility to cancer. Nat Genet Thyroid Cancer, G. Thomas, E.D. Williams, and A. Karaoglou, eds. 32:185-190. Luxembourg: World Scientific Publishing. Stadler, L.J. 1928a. Genetic effects of x-rays in maize. Proc Natl Acad Sci Smida, J., K. Salassidis, L. Hieber, H. Zitzelsberger, A.M. Kellerer, E.P. USA 14:69-75. Demidchik, T. Negele, F. Spelsberg, E. Lengfelder, M. Werner, and M. Stadler, L.J. 1928b. Mutations in barley induced by x-rays and radium. Bauchinger. 1999b. Distinct frequency of RET rearrangements in papil- Science 68:186. lary thyroid carcinomas of children and adults from Belarus. Int J Can- Stead, J.D., and A.J. Jeffreys. 2000. Allele diversity and germline mutation cer 80:32-38. at the insulin minisatellite. Hum Mol Genet 9:713-723. Smith, C. 1975. Quantitative inheritance. Pp. 382-441 in Text Book of Hu- Stecca, C., and G.B. Gerber. 1998. Adaptive response to DNA-damaging man Genetics, G. Fraser and O. Mayo, eds. London: Blackwell. agents: a review of potential mechanisms. Biochem Pharmacol 55: Smith, J.C., C.R. Newton, A. Alves, R. Anwar, D. Jenner, and A.F. 941-951. Markham. 1990. Highly polymorphic minisatellite DNA probes. Fur- Steiner, M., W. Burkart, B. Grosche, U. Kaletsch, and J. Michaelis. 1998. ther evaluation for individual identification and paternity testing. J Fo- Trends in infant leukaemia in West Germany in relation to in utero rensic Sci Soc 30:3-18. exposure due to the Chernobyl accident. Radiat Environ Bioph 37: Smith, J.W., and H. Inskip. 1985. Estimation of below measurement thresh- 87-93. old doses following the remeasurement of a sample of old films. J Soc Radiol Prot 5:159-164.

OCR for page 337
REFERENCES 367 Stern, F.B., R.A. Waxweiler, J.J. Beaumont, S.T. Lee, R.A. Rinsky, R.D. Suzuki, K., R. Takahara, S. Kodama, and M. Watanabe. 1998. In situ detec- Zumwalde, W.E. Halperin, P.J. Bierbaum, P.J. Landrigan, and W.E. tion of chromosome bridge formation and delayed reproductive death in Murray Jr. 1986. A case-control study of leukemia at a naval nuclear normal human embryonic cells surviving X irradiation. Radiat Res shipyard. Am J Epidemiol 123:980-992. 150:375-381. Stewart, A.M., and G.W. Kneale. 1996. Relations between age at occupa- Swanson, R.L., N.J. Morey, P.W. Doetsch, and S. Jinks-Robertson. 1999. tional exposure to ionising radiation and cancer risk. Occup Environ Overlapping specificities of base excision repair, nucleotide excision Med 53:225-230. repair, recombination, and translesion synthesis pathways for DNA base Stewart, A., J. Webb, and D. Hewitt. 1958. A survey of childhood malig- damage in Saccharomyces cerevisiae. Mol Cell Biol 19:2929-2935. nancies. Brit Med J 30:1495-1508. Swerdlow, A.J., M.J. Schoemaker, R. Allerton, A. Horwich, J.A. Barber, D. Stewart, J.R., and L.F. Fajardo. 1984. Radiation-induced heart disease: an Cunningham, T.A. Lister, A.Z. Rohatiner, G. Vaughan Hudson, M.V. update. Prog Cardiovasc Dis 27:173-194. Williams, and D.C. Linch. 2001. Lung cancer after Hodgkin’s disease: Stewart, J.R., L.F. Fajardo, S.M. Gillette, and L.S. Constine. 1995. Radia- a nested case-control study of the relation to treatment. J Clin Oncol tion injury to the heart. Int J Radiat Oncol 31:1205-1211. 19:1610-1618. Storer, J.B., and R.L. Ullrich. 1983. Life shortening in BALB/c mice fol- Szymanska, H., M. Sitarz, E. Krysiak, J. Piskorowska, A. Czarnomska, H. lowing brief, protracted, or fractionated exposures to neutrons. Radiat Skurzak, A.A. Hart, D. de Jong, and P. Demant. 1999. Genetics of sus- Res 96:335-347. ceptibility to radiation-induced lymphomas, leukemias and lung tumors Storer, J.B., L.J. Serrano, E.B. Darden Jr., M.C. Jernigan, and R.L. Ullrich. studied in recombinant congenic strains. Int J Cancer 83:674-678. 1979. Life shortening in RFM and BALB/c mice as a function of radia- Taalman, R.D., N.G. Jaspers, J.M. Scheres, J. de Wit, and T.W. Hustinx. tion quality, dose, and dose rate. Radiat Res 78:122-161. 1983. Hypersensitivity to ionizing radiation, in vitro, in a new chromo- Storer, J.B., T.J. Mitchell, and R.L. Ullrich. 1982. Causes of death and their somal breakage disorder, the Nijmegen Breakage Syndrome. Mutat Res contribution to radiation-induced life shortening in intact and ovariecto- 112:23-32. mized mice. Radiat Res 89:618-643. Takahashi, T., M.J. Schoemaker, K.R. Trott, S.L. Simon, K. Fujimori, N. Storer, J.B., T.J. Mitchell, and R.J. Fry. 1988. Extrapolation of the relative Nakashima, A. Fukao, and H. Saito. 2003. The relationship of thyroid risk of radiogenic neoplasms across mouse strains and to man. Radiat cancer with radiation exposure from nuclear weapon testing in the Res 114:331-353. Marshall Islands. J Epidemiol 13:99-107. Storm, H.H., M. Andersson, J.D. Boice, M. Blettner, M. Stovall, H.T. Tamaki, K., C.A. May, Y.E. Dubrova, and A.J. Jeffreys. 1999. Extremely Mouridsen, P. Dombernowsky, C. Rose, A. Jacobsen, and M. Pedersen. complex repeat shuffling during germline mutation at human 1992. Adjuvant radiotherapy and risk of contralateral breast cancer. J minisatellite B6.7. Hum Mol Genet 8:879-888. Natl Cancer Inst 84:1245-1250. Tanaka, K., N.J. Tchaijunusova, T. Takatsuji, B.I. Gusev, A.K. Sakerbaev, Storm, H.H., A.E. Prisyazhniuk, A.E. Okeanov, V.K. Ivanov, and L. Gulak. M. Hoshi, and N. Kamada. 2000. High incidence of micronuclei in lym- 1996. Development of infrastructure for epidemiological studies in the phocytes from residents of the area near the Semipalatinsk nuclear ex- three CIS republics. The Radiological Consequences of the Chernobyl plosion test site. J Radiat Res 41:45-54. Accident. Proceedings of the First International Conference, Minsk, Tankersley, W.G., C.M. West, J.E. Watson, and J.L. Reagan. 1996. Retro- Belarus, A. Karaoglou, G. Desmet, G.N. Kelly, and others, eds. ECSC- spective assessment of radiation exposures at or below the minimum EC-EAEC, Brussels, Luxembourg. detectable level at a federal nuclear reactor facility. App Occ Env Hyg Strasser, A., A.W. Harris, T. Jacks, and S. Cory. 1994. DNA damage can 11:330-333. induce apoptosis in proliferating lymphoid cells via p53-independent Tauchi, H., S. Endo, K. Eguchi-Kasai, Y. Furusawa, M. Suzuki, S. mechanisms inhibitable by Bcl-2. Cell 79:329-339. Matsuura, K. Ando, N. Nakamura, S. Sawada, and K. Komatsu. 1999. Strather, J.W., C.R. Muirheard, A.A. Edwards, J.D. Harrison, D.C. Lloyd, Cell cycle and LET dependence for radiation-induced mutation: a pos- and N.R. Wood. 1988. Health Effects Models Developed from the 1988 sible mechanism for reversed dose-rate effect. J Radiat Res UNSCEAR Report. NRPBR226. Chilton, UK: National Radiological 40(Suppl):45-52. Protection Board. Tawn, E.J., C.A. Whitehouse, D. Holdsworth, S. Morris, and R.E. Tarone. Straume, T. 1991. Health Risks from Exposure to Tritium. Lawrence 2000a. Chromosome analysis of workers occupationally exposed to ra- Livermore National Laboratory Report. diation at the Sellafield nuclear facility. Int J Radiat Biol 76:355-365. Straume, T. 1996. Risk implications of the neutron discrepancy in the Tawn, E.J., C.A. Whitehouse, and F.A. Martin. 2000b. Sequential chromo- Hiroshima DS86 dosimetry system. Radiat Prot Dosim 67:9-12. some aberration analysis following radiotherapy—no evidence for en- Straume, T., and A.L. Carsten. 1993. Tritium radiobiology and relative bio- hanced genomic instability. Mutat Res 465:45-51. logical effectiveness. Health Phys 65:657-672. Tawn, E.J., C.A. Whitehouse, and R.E. Tarone. 2004. FISH chromosome Straume, T., S.D. Egbert, W.A. Woolson, R.C. Finkel, P.W. Kubik, H.E. aberration analysis on retired radiation workers from the Sellafield Gove, P. Sharma, and M. Hoshi. 1992. Neutron discrepancies in the nuclear facility. Radiat Res 162:249-256. DS86 Hiroshima dosimetry system. Health Phys 63:421-426. Taylor, A.M.R. 1983. The effect of radiation on the chromosomes of pa- Strong, L.C. 1977. Genetic and environmental interactions. Cancer 40:1861- tients with an unusual cancer susceptibility. Pp. 166-169 in Radiation 1866. Induced Chromosome Damage in Man, T. Ishikara and M. Sasaki, eds. Strong, L.C., and W.R. Williams. 1987. The genetic implications of long- New York: A.R. Liss. term survival of childhood cancer. A conceptual framework. Am J Taylor, A.M.R., D. Scott, C.F. Arlett, and J. Cole. 1994a. Ataxia-telang- Pediat Hematol 9:99-103. iectasia: the effect of a pleiotropic gene. Int J Radiat Biol 66:S5-S201. Stsjazhko, V.A., A.F. Tsyb, N.D. Tronko, G. Souchkevitch, and K.F. Taylor, J.A., M.A. Watson, T.R. Devereux, R.Y. Michels, G. Saccomanno, Baverstock. 1995. Childhood thyroid cancer since accident at and M. Anderson. 1994b. p53 mutation hotspot in radon-associated lung Chernobyl. Brit Med J 310:801. cancer. Lancet 343:86-87. Sturzbecher, H.W., B. Donzelmann, W. Henning, U. Knippschild, and S. Taylor, N.A. 1991. Estimation of dose received when dosemeter results are Buchhop. 1996. p53 is linked directly to homologous recombination recorded below a threshold level. J Radiol Prot 3:191-198. processes via RAD51/RecA protein interaction. EMBO J 15:1992-2002. Tedeschi, B., D. Caporossi, P. Vernole, L. Padovani, M. Appolloni, P. Sugenoya, A., K. Asanuma, Y. Hama, H. Masuda, G.S. Skidanenko, A.T. Anzidei, and F. Mauro. 1995. Do human lymphocytes exposed to the Anatoliebna, K. Koike, A. Komiyama, and F. Iida. 1995. Thyroid ab- fallout of the Chernobyl accident exhibit an adaptive response? 2. Chal- normalities among children in the contaminated area related to the lenge with bleomycin. Mutat Res 332:39-44. Chernobyl accident. Thyroid 5:29-33.

OCR for page 337
368 REFERENCES Tedeschi, B., D. Caporossi, P. Vernole, L. Padovani, and F. Mauro. 1996. Tokunaga, M., C.E. Landd, S. Tokuoka, I. Nishimori, M. Soda, and S. Do human lymphocytes exposed to the fallout of the Chernobyl acci- Akiba. 1994. Incidence of female breast cancer among atomic bomb dent exhibit an adaptive response? III. Challenge with bleomycin in survivors, 1950-1985. Radiat Res 138:209-223. lymphocytes from children hit by the initial acute dose of ionizing ra- Tomlinson, I., and W. Bodmer. 1999. Selection, the mutation rate and can- diation. Mutat Res 354:77-80. cer: ensuring that the tail does not wag the dog. Nat Med 5:11-12. Telle, M.A. 1995. Historique des pratiques de dosimetrie au CEA: Tomonaga, M.T., R.L. Matsuo, J.M. Carter, K. Bennett, F. Kuriyama, F. metrologie, enreistrement des doses et criteres de surveillance. Institut Imanaka, S. Kusumi, K. Mabuci, A. Kuramoto, N. Kamada, M. de Protection et de Surete Nucleaire. Fontenay-aux-Roses, France. Ichimaru, A.V. Pisciotta, and C.C. Finch. 1991. Differential effects of Telle-Lamberton, M.A., E. Auperin, J. Chemali, and D. Bergot. 1998. Re- atomic bomb irradiation in inducing major leukemia types: analysis of constitution a posteriori des expositions professionnelles aux open-city cases including the Life Span Study cohort based upon up- rayonnements ionisants: Incertitudes liees aux seuils de detection des dated diagnostic systems and the Dosimetry System 1986 (DS86). dosimetres. Revue de Medecine du Travail 25:37-41. Hiroshima, Japan: Radiation Effects Research Foundation. Telle-Lamberton, M., D. Bergot, M. Gagneau, E. Samson, J.M. Giraud, Tondel, M., G. Carlsson, L. Hardell, M. Eriksson, S. Jakobsson, U. Flodin, M.O. Neron, and P. Hubert. 2004. Cancer mortality among French A. Skoldestig, and O. Axelson. 1996. Incidence of neoplasms in ages 0- Atomic Energy Commission workers. Am J Ind Med 45:34-44. 19 y in parts of Sweden with high 137Cs fallout after the Chernobyl Teraoka, S.N., K.E. Malone, D.R. Doody, N.M. Suter, E.A. Ostrander, J.R. accident. Health Phys 71:947-950. Daling, and P. Concannon. 2001. Increased frequency of ATM muta- Travis, L.B., R.E. Curtis, J.D. Boice, B.F. Hankey, and J.F. Fraumeni. 1991. tions in breast carcinoma patients with early onset disease and positive Second cancers following non-Hodgkin’s lymphoma. Cancer 67:2002- family history. Cancer 92:479-487. 2009. Terasima, T., and L.J. Tolmach. 1963. X-ray sensitivity and DNA synthesis Travis, L.B., R.E. Curtis, H. Storm, P. Hall, E. Holowaty, F.E. van Leeuwen, in synchronous populations of HeLa cells. Science 140:490-492. B.A. Kohler, E. Pukkala, C.F. Lynch, M. Andersson, K. Bergfeldt, E.A. Thacker, J. 1986. The nature of mutants induced by ionising radiation in Clarke, T. Wiklund, G. Stoter, M. Gospodarowicz, J. Sturgeon, J.F. cultured hamster cells. III. Molecular characterization of HPRT-defi- Fraumeni Jr., and J.D. Boice Jr. 1997. Risk of second malignant neo- cient mutants induced by gamma-rays or alpha-particles showing that plasms among long-term survivors of testicular cancer. J Natl Cancer the majority have deletions of all or part of the hprt gene. Mutat Res Inst 89:1429-1439. 160:267-275. Travis, L.B., E.J. Holowaty, K. Bergfeldt, C.F. Lynch, B.A. Kohler, T. Thacker, J. 1992. Radiation-induced mutation in mammalian cells at low Wiklund, R.E. Curtis, P. Hall, M. Andersson, E. Pukkala, J. Sturgeon, doses and dose rates. Adv Radiat Biol 16:77-124. and M. Stovall. 1999. Risk of leukemia after platinum-based chemo- Thacker, J., and R. Cox. 1983. The relationship between specific chromo- therapy for ovarian cancer. N Engl J Med 340:351-357. some aberrations and radiation-induced mutations in cultured mamma- Travis, L.B., M. Andersson, M. Gospodarowicz, F.E. van Leeuwen, K. lian cells. Pp. 235-275 in Radiation-Induced Chromosome Damage in Bergfeldt, C.F. Lynch, R.E. Curtis, B.A. Kohler, T. Wiklund, H. Storm, Man, T. Ishihara and M.S. Sasaki, eds. New York: Liss. E. Holowaty, P. Hall, E. Pukkala, D.T. Sleijfer, E.A. Clarke, J.D. Boice Thacker, J., A. Stretch, and M.A. Stephens. 1979. Mutation and inactiva- Jr., M. Stovall, and E. Gilbert. 2000. Treatment-associated leukemia tion of cultured mammalian cells exposed to beams of accelerated heavy following testicular cancer. J Natl Cancer Inst 92:1165-1171. ions. II. Chinese hamster V79 cells. Int J Radiat Biol Re 36:137-148. Travis, L.B., M. Gospodarowicz, R.E. Curtis, E.A. Clarke, M. Andersson, Thacker, J., A.N. Ganesh, A. Stretch, D.M. Benjamin, A.J. Zahalsky, and B. Glimelius, T. Joensuu, C.F. Lynch, F.E. van Leeuwen, E. Holowaty, E.A. Hendrickson. 1994. Gene mutation and V(D)J recombination in H. Storm, I. Glimelius, E. Pukkala, M. Stovall, J.F. Fraumeni Jr., J.D. the radiosensitive irs lines. Mutagenesis 9:163-168. Boice Jr., and E. Gilbert. 2002. Lung cancer following chemotherapy Thomas, G.A., and E.D. Williams. 1991. Evidence for and possible mecha- and radiotherapy for Hodgkin’s disease. J Natl Cancer Inst 94:182-192. nisms of non-genotoxic carcinogenesis in the rodent thyroid. Mutat Res Travis, L.B, D.A. Hill, G.M. Dores, M. Gospodarowicz, F.E. van Leeuwen, 248:357-370. E. Holowaty, B. Glimelius, M. Andersson, T. Wiklund, C.F. Lynch, Thomas, D., S. Darby, F. Fagnani, P. Hubert, M. Vaeth, and K. Weiss. M.B. van’t Veer, I. Glimelius, H. Storm, E. Pukkala, M. Stovall, R. 1992. Definition and estimation of lifetime detriment from radiation Curtis, J.D. Boice Jr., and E. Gilbert. 2003. Breast cancer following exposures: principles and methods. Health Phys 63:259-272. radiotherapy and chemotherapy among young women with Hodgkin Thompson, D.E., K. Mabuchi, E. Ron, M. Soda, M. Tokunaga, S. Ochikubo, disease. J Am Med Assoc 290:465-475; erratum in J Am Med Assoc S. Sugimoto, T. Ikeda, M. Terasaki, S. Izumi, and D.L. Preston. 1994. 290:1318. Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958- Trenz, K., A. Rothfuss, P. Schutz, and G. Speit. 2002. Mutagen sensitivity 1987. Radiat Res 137:S17-S67. of peripheral blood from women carrying a BRCA1 or BRCA2 muta- Thompson, L.H. 1996. Evidence that mammalian cells possess homologous tion. Mutat Res 500:89-96. recombinational repair pathways. Mutat Res 363:77-88. Trepicchio, W.L., and T.G. Krontiris. 1992. Members of the rel/NF_B fam- Thompson, L.H., and R.M. Humphrey. 1968. Response of mouse L-P59 ily of transcriptional regulatory proteins bind the HRAS1 minisatellite cells to x-irradiation in the G2 phase. Int J Radiat Biol 15:181-184. DNA sequence. Nucleic Acids Res 20:2427-2434. Thompson, L.H., and D. Schild. 1999. The contribution of homologous Trimble, B.K., and J.H. Doughty. 1974. The amount of hereditary disease recombination in preserving genome integrity in mammalian cells. in human populations. Ann Hum Genet 38:199-223. Biochimie 81:87-105. Tripodis, N., A.A. Hart, R.J. Fijneman, and P. Demant. 2001. Complexity Thorpe, G.W., C.S. Fong, N. Alic, V.J. Higgins, and I.W. Dawes. 2004. of lung cancer modifiers: mapping of thirty genes and twenty-five inter- Cells have distinct mechanisms to maintain protection against different actions in half of the mouse genome. J Natl Cancer Inst 93:1484-1491. reactive oxygen species: oxidative-stress-response genes. Proc Natl Trivedi, A., and M.A. Hannan. 2004. Radiation and cardiovascular dis- Acad Sci USA 101:6564-6569. eases. J Environ Pathol Toxicol Oncol 23:99-106. Tishkoff, D.X., N. Filosi, G.M. Gaida, and R.D. Kolodner. 1997. A novel Tronko, M.D., T.I. Bogdanova, I.V. Komissarenko, O.V. Epstein, V. mutation avoidance mechanism dependent on S. cerevisiae RAD27 is Oliynyk, A. Kovalenko, I.A. Likhtarev, I. Kairo, S.B. Peters, and V.A. distinct from DNA mismatch repair. Cell 88:253-263. LiVolsi. 1999. Thyroid carcinoma in children and adolescents in Tokunaga, M., C.E. Land, Y. Aoki, T. Yamamoto, M. Asano, E. Sato, S. Ukraine after the Chernobyl nuclear accident: statistical data and Tokuoka, G. Sakamoto, and D.L. Page. 1993. Proliferative and clinicomorphologic characteristics. Cancer 86:149-156. nonproliferative breast disease in atomic bomb survivors. Results of a histopathologic review of autopsy breast tissue. Cancer 72:1657-1665.

OCR for page 337
REFERENCES 369 Tronko, N.D., T.I. Bogdanova, O.V. Epstein, V.A. Oleynyk, I.V. Ullrich, R.L., M.C. Jernigan, G.E. Cosgrove, L.C. Satterfield, N.D. Bowles, Komissarenko, S.I. Rybakov, A.E. Kovalenko, V.P. Tereshchenko, I.A. and J.B. Storer. 1976. The influence of dose and dose rate on the inci- Likhtarev, I.A. Kairo, V.M. Shpak, and N.I. Chepurnoy. 2002. Thyroid dence of neoplastic disease in RFM mice after neutron irradiation. cancer in children and adolescents of Ukraine having been exposed as a Radiat Res 68:115-131. result of the Chernobyl accident (15-year expertise of investigations). Ullrich, R.L., M.C. Jernigan, L.C. Satterfield, and N.D. Bowles. 1987. Ra- Int J Radiat Med 4:222-232. diation carcinogenesis: time-dose relationships. Radiat Res 111: Tsyb, A.F., A.N. Dedenkov, V.K. Ivanov, V.F. Stepanenko, and V.V. 179-184. Pozhidaev. 1989. The development of an all-Union registry of persons UNSCEAR (United Nations Scientific Committee on the Effects of Atomic exposed to radiation resulting from the accident at the Chernobyl atomic Radiation). 1958. The 1958 Report to the General Assembly with An- power station. Med Radiol 34:3-6. nexes. New York: United Nations. Tucker, J.D., K.J. Sorensen, C.S. Chu, D.O. Nelson, M.J. Ramsey, C. UNSCEAR (United Nations Scientific Committee on the Effects of Atomic Urlando, and J.A. Heddle. 1998. The accumulation of chromosome ab- Radiation). 1962. The 1962 Report to the General Assembly with An- errations and Dlb-1 mutations in mice with highly fractionated expo- nexes. New York: United Nations. sure to gamma radiation. Mutat Res 400:321-335. UNSCEAR (United Nations Scientific Committee on the Effects of Atomic Tucker, M.A., G.J. D’Angio, J.D. Boice Jr., L.C. Strong, F.P. Li, M. Stovall, Radiation). 1972. The 1972 Report to the General Assembly with An- B.J. Stone, D.M. Green, F. Lombardi, W. Newton, R.N. Hoover, and nexes. New York: United Nations. J.F. Fraumeni Jr. 1987a. Bone sarcomas linked to radiotherapy and che- UNSCEAR (United Nations Scientific Committee on the Effects of Atomic motherapy in children. N Engl J Med 317:588-593. Radiation). 1977. The 1977 Report to the General Assembly with An- Tucker, M.A., A.T. Meadows, J.D. Boice Jr., M. Stovall, O. Oberlin, B.J. nexes. New York: United Nations. Stone, J. Birch, P.A. Voute, R.N. Hoover, and J.F. Fraumeni Jr. 1987b. UNSCEAR (United Nations Scientific Committee on the Effects of Atomic Leukemia after therapy with alkylating agents for childhood cancer. J Radiation). 1982. Ionizing Radiation: Sources and Biological Effects. Natl Cancer Inst 78:459-464. The 1982 Report to the General Assembly with Annexes. New York: Tucker, M.A., P.H. Morris Jones, J.D. Boice Jr., L.L. Robison, B.J. Stone, United Nations. M. Stovall, R.D. Jenkin, J.H. Lubin, E.S. Baum, S.E. Siegel, A.T. Mead- UNSCEAR (United Nations Scientific Committee on the Effects of Atomic ows, R.N. Hoover, and J.F. Fraumeni Jr. 1991. Therapeutic radiation at Radiation). 1986. Genetic and Somatic Effects of Ionizing Radiation. a young age is linked to secondary thyroid cancer. Cancer Res 51:2885- The 1986 Report to the General Assembly with Annexes. New York: 2888. United Nations. Tukiendorf, A., G. Krasowski, and Z. Rybak. 2003. Thyroid cancer morbid- UNSCEAR (United Nations Scientific Committee on the Effects of Atomic ity in Opole Province, Poland, after Chernobyl disaster. Cent Eur J Pub- Radiation). 1988. Sources, Effects, and Risks of Ionizing Radiation. lic Health 11:98-101. The 1988 Report to the General Assembly with Annexes. New York: Tusher, V.G., R. Tibshirani, and G. Chu. 2001. Significance analysis of United Nations. microarrays applied to the ionizing radiation response. Proc Natl Acad UNSCEAR (United Nations Scientific Committee on the Effects of Atomic Sci USA 98:5116-5121. Radiation). 1993. Sources and Effects of Ionizing Radiation. 1993 Re- Ueno, A.M., D.B. Vannais, D.L. Gustafson, J.C. Wong, and C.A. Waldren. port to the General Assembly, with Scientific Annexes. New York: 1996. A low, adaptive dose of gamma-rays reduced the number and United Nations. altered the spectrum of S1 mutants in human-hamster hybrid AL cells. UNSCEAR (United Nations Scientific Committee on the Effects of Atomic Mutat Res 358:161-169. Radiation). 1994. Sources and Effects of Ionizing Radiation. 1994 Re- Ullrich, R.L. 1983. Tumor induction in BALB/c female mice after fission port to the General Assembly, with Scientific Annexes. Annex B Adap- neutron or gamma irradiation. Radiat Res 93:506-515. tive Responses to Radiation in Cells and Organisms. New York: United Ullrich, R.L. 1984. Tumor induction in BALB/c mice after fractionated or Nations. protracted exposures to fission-spectrum neutrons. Radiat Res 97: UNSCEAR (United Nations Scientific Committee on the Effects of Atomic 587-597. Radiation). 1996. Sources and Effects of Ionizing Radiation. 1996 Re- Ullrich, R.L. 1986. The rate of progression of radiation-transformed mam- port to the General Assembly with Scientific Annex. New York: United mary epithelial cells is enhanced after low-dose-rate neutron irradia- Nations. tion. Radiat Res 105:68-75. UNSCEAR (United Nations Scientific Committee on the Effects of Atomic Ullrich, R.L. 1999. Risks for radiation-induced breast cancer: the debate Radiation). 2000a. Sources and Effects of Ionizing Radiation. continues. Radiat Res 151:123-124. UNSCEAR Report to the General Assembly, Volume I: Sources. New Ullrich, R.L., and C.M. Davis. 1999. Radiation-induced cytogenetic insta- York: United Nations. bility in vivo. Radiat Res 152:170-173. UNSCEAR (United Nations Scientific Committee on the Effects of Atomic Ullrich, R.L., and B. Ponnaiya. 1998. Radiation-induced instability and its Radiation). 2000b. Sources and Effects of Ionizing Radiation. relation to radiation carcinogenesis. Int J Radiat Biol 74:747-754. UNSCEAR Report to the General Assembly, Volume II: Effects. New Ullrich, R.L., and R.J. Preston. 1987. Myeloid leukemia in male RFM mice York: United Nations. following irradiation with fission spectrum neutrons or gamma rays. UNSCEAR (United Nations Scientific Committee on the Effects of Atomic Radiat Res 109:165-170. Radiation). 2001. United Nations Scientific Committee on the Effects Ullrich, R.L., and J.B. Storer. 1979a. Influence of gamma irradiation on the of Atomic Radiation. Hereditary Effects of Radiation. The 2002 Report development of neoplastic disease in mice. I. Reticular tissue tumors. to the General Assembly with Scientific Annex. New York: United Radiat Res 80:303-316. Nations. Ullrich, R.L., and J.B. Storer. 1979b. Influence of gamma irradiation on the Upton, A.C. 2000. Why the concept of hormesis has not been incorporated development of neoplastic disease in mice. II. Solid tumors. Radiat Res into mainstream radiation health theory: radiation perspective. Hum 80:317-324. Ecol Risk Assess 6:249-271. Ullrich, R.L., and J.B. Storer. 1979c. Influence of gamma irradiation on the Upton, A.C., M.L. Randolph, J.W. Conklin, M.A. Kastenbaum, M. Slater, development of neoplastic disease in mice. III. Dose-rate effects. Radiat G.S. Melville Jr., F.P. Conte, and J.A. Sproul Jr. 1970. Late effects of Res 80:325-342. fast neutrons and gamma-rays in mice as influenced by the dose rate of irradiation: induction of neoplasia. Radiat Res 41:467-491.

OCR for page 337
370 REFERENCES Urquhart, J.D., R.J. Black, M.J. Muirhead, L. Sharp, M. Maxwell, O.B. Vogelstein, B., and K.W. Kinzler. 1993. The multistep nature of cancer. Eden, and D.A. Jones. 1991. Case-control study of leukaemia and non- Trends Genet 9:138-141. Hodgkin’s lymphoma in children in Caithness near the Dounreay Vykhovanets, E.V., V.P. Chernyshov, I.I. Slukvin, Y.G. Antipkin, A.N. nuclear installation. Brit Med J 302:687-692; erratum in Brit Med J Vasyuk, H.F. Klimenko, and K.W. Strauss. 1997. I-131 dose-dependent 302:818. thyroid autoimmune disorders in children living around Chernobyl. Clin Vaeth, M., and D.A. Pierce. 1990. Calculating excess lifetime risk in rela- Immunol Immnop 84:251-259. tive risk models. Environ Health Persp 87:83-94. Wakeford, R., and M.P. Little. 2003. Risk coefficients for childhood cancer Vahakangas, K.H., J.M. Samet, R.A. Metcalf, J.A. Welsh, W.P. Bennett, after intrauterine irradiation: a review. Int J Radiat Biol 79:293-309. D.P. Lane, and C.C. Harris. 1992. Mutations of p53 and ras genes in Wakeford, R., and L. Parker. 1996. Leukaemia and non-Hodgkin’s lym- radon-associated lung cancer from uranium miners. Lancet 339:576- phoma in young persons resident in small areas of West Cumbria in 580. relation to paternal preconceptional irradiation. Brit J Cancer 73: van der Houven van Oordt, C.W., R. Smits, T.G. Schouten, J.J. Houwing- 672-679. Duistermaat, S.L. Williamson, A. Luz, P. Meera Khan, A.J. van der Eb, Waldren, C.A. 2004. Classical radiation biology dogma, bystander effects M.L. Breuer, and R. Fodde. 1999. The genetic background modifies the and paradigm shifts. Hum Exp Toxicol 23:95-100. spontaneous and x-ray-induced tumor spectrum in the Apc1638N mouse Waller, L.A., B.W. Turnbull, G. Gustafsson, U. Hjalmars, and B. model. Gene Chromosomes Cancer 24:191-198. Andersson. 1995. Detection and assessment of clusters of disease: an van Leeuwen, F.E., W.J. Klokman, M. Stovall, A. Hagenbeek, A.W. van application to nuclear power plant facilities and childhood leukaemia in den Belt-Dusebout, R. Noyon, J.D. Boice Jr., J.M. Burgers, and R. Sweden. Stat Med 14:3-16. Somers. 1995. Roles of radiotherapy and smoking in lung cancer fol- Wang, B., H. Ohyama, T. Nose, H. Itsukaichi, T. Nakajima, O. Yukawa, T. lowing Hodgkin’s disease. J Natl Cancer Inst 87:1530-1537. Odaka, K. Tanaka, E. Kojima, T. Yamada, and I. Hayata. 1998. Adap- van Leeuwen, F.E., W.J. Klokman, M. Stovall, E.C. Dahler, M.B. van’t tive response in embryogenesis: I. Dose and timing of radiation for re- Veer, E.M. Noordijk, M.A. Crommelin, B.M. Aleman, A. Broeks, M. duction in prenatal death and congenital malformation during the late Gospodarowicz, L.B. Travis, and N.S. Russell. 2003. Roles of radiation period of organogenesis. Radiat Res 150:120-122. dose, chemotherapy, and hormonal factors in breast cancer following Wang, J.X., J.D. Boice Jr., B.X. Li, J.Y. Zhang, and J.F. Fraumeni Jr. 1988. Hodgkin’s disease. J Natl Cancer Inst 95:971-980. Cancer among medical diagnostic x-ray workers in China. J Natl Can- van Wezel, T., A.P. Stassen, C.J. Moen, A.A. Hart, M.A. van der Valk, and cer Inst 80:344-350. P. Demant. 1996. Gene interaction and single gene effects in colon tu- Wang, Y., D. Cortez, P. Yazdi, N. Neff, S.J. Elledge, and J. Qin. 2000. mour susceptibility in mice. Nat Genet 14:468-470. BASC, a super complex of BRCA1-associated proteins involved in the Venitt, S., and P.J. Biggs. 1994. Radon, mycotoxins, p53, and uranium recognition and repair of aberrant DNA structures. Genes Dev 14: mining. Lancet 343:795. 927-939. Verger, P., O. Catelinois, M. Tirmarche, L. Cherie-Challine, P. Pirard, M. Wang, Z.Y., J.D. Boice, L.X. Wei, G.W. Beebe, Y.R. Zha, M.M. Kaplan, Colonna, and P. Hubert. 2003. Thyroid cancers in France and the Z.F. Tao, H.R. Maxon III, S.Z. Zhang, A.B. Schneider, B. Tan, T.A. Chernobyl accident: risk assessment and recommendations for improv- Wesseler, D. Chen, A.G. Ershow, R.A. Kleinerman, L.G. Littlefield, ing epidemiological knowledge. Health Phys 85:323-329. and D. Preston. 1990. Thyroid nodularity and chromosome aberrations Vergnaud, G., and F. Denoeud. 2000. Minisatellites: mutability and ge- among women in areas of high background radiation in China. J Natl nome architecture. Genome Res 10:899-907. Cancer Inst 82:478-485. Vermiglio, F., M.G. Castagna, E. Volnova, V.P. Lo Presti, M. Moleti, M.A. Ward, J.F. 1981. Some biochemical consequences of the spatial distribution Violi, A. Artemisia, and F. Trimarchi. 1999. Post-Chernobyl increased of ionizing radiation-produced free radicals. Radiat Res 86:185-195. prevalence of humoral thyroid autoimmunity in children and adoles- Ward, J.F. 1988. DNA damage produced by ionizing radiation in mamma- cents from a moderately iodine-deficient area in Russia. Thyroid 9: lian cells: identities, mechanism of formation, and repairability. Prog 781-786. Nucleic Acid Res 35:95-125. Viel, J.F., D. Pobel, and A. Carre. 1995. Incidence of leukaemia in young Ward, J.F. 1994. The complexity of DNA damage—relevance to biological people around the La Hague nuclear waste reprocessing plant: a sensi- consequences. Int J Radiat Biol 66:427-432. tivity analysis. Stat Med 14:2459-2472. Ward, J.F. 2002. The radiation-induced lesions which trigger the bystander Vijayalaxmi, B.Z. Leal, T.S. Deahl, and M.L. Meltz. 1995. Variability in effect. Mutat Res 499:151-154. adaptive response to low dose radiation in human blood lymphocytes: Ward, J.F., W.F. Blakely, and E.I. Joner. 1985. Mammalian cells are not consistent results from chromosome aberrations and micronuclei. Mutat killed by DNA single-strand breaks caused by hydroxyl radicals from Res 348:45-50. hydrogen peroxide. Radiat Res 103:383-392. Vilenchik, M.M., and A.G. Knudson Jr. 2000. Inverse radiation dose-rate Ward, J.F., C.L. Limoli, P.M. Calabro-Jones, and J. Aguilera. 1991. An effects on somatic and germ-line mutations and DNA damage rates. examination of the repair saturation hypothesis for describing shoul- Proc Natl Acad Sci USA 97:5381-5386. dered survival curves. Radiat Res 127:90-96. Villeneuve, P.J., and H.I. Morrison. 1997. Coronary heart disease mortality Watanabe, M., and M. Horikawa. 1980. Analyses of differential sensitivi- among Newfoundland fluorspar miners. Scan J Work Env Health ties of synchronized HeLa S3 cells to radiations and chemical carcino- 23:221-226. gens during the cell cycle. Par V. Radiation- and chemical carcinogen- Voehringer, D.W., D.L. Hirschberg, J. Xiao, Q. Lu, M. Roederer, C.B. Lock, induced mutagenesis. Mutat Res 71:219-231. L.A. Herzenberg, L. Steinman, and L.A. Herzenberg. 2000. Gene Waters, T.R., P. Gallinari, J. Jiricny, and P.F. Swann. 1999. Human thym- microarray identification of redox and mitochondrial elements that con- ine DNA glycosylase binds to apurinic sites in DNA but is displaced by trol resistance or sensitivity to apoptosis. Proc Natl Acad Sci USA human apurinic endonuclease 1. J Biol Chem 274:67-74. 97:2680-2685. Watkins, J.P., D.L. Cragle, E.L. Frome, J.L. Reagan, C.M. West, D. Voelz, G.L., J.N. Lawrence, and E.R. Johnson. 1997. Fifty years of pluto- Crawford-Brown, and W.G. Tankersley. 1997. Collection, validation, nium exposure to the Manhattan Project plutonium workers: an update. and treatment of data for mortality study of nuclear industry workers. Health Phys 73:611-619. Appl Occ Env Hyg 12:195-205. Vogel, F. 1979. Genetics of retinoblastoma. Hum Genet 52:1-54. Watson, G.E., S.A. Lorimore, and E.G. Wright. 1996. Long-term in vivo Vogel, F., and Motulsky, A.G. 1997. Human Genetics: Problems and Ap- transmission of alpha-particle-induced chromosomal instability in mu- proaches. Berlin: Springer. rine haemopoietic cells. Int J Radiat Biol 69:175-182.

OCR for page 337
REFERENCES 371 Watson, G.E., D.A. Pocock, D. Papworth, S.A. Lorimore, and E.G. Wright. Wojcik, A., K. Bonk, W.U. Muller, C. Streffer, U. Weissenborn, and G. 2001. In vivo chromosomal instability and transmissible aberrations in Obe. 1992. Absence of adaptive response to low doses of x-rays in pre- the progeny of haemopoietic stem cells induced by high- and low-LET implantation embryos and spleen lymphocytes of an inbred mouse strain radiations. Int J Radiat Biol 77:409-417. as compared to human peripheral lymphocytes: a cytogenetic study. Int Weil, M.M., C. Xia, X. Xia, X. Gu, C.I. Amos, and K.A. Mason. 2001. A J Radiat Biol 62:177-186. chromosome 15 quantitative trait locus controls levels of radiation-in- Wolf, C., J. Lafuma, R. Masse, M. Morin, and A.M. Kellerer. 2000. Neu- duced jejunal crypt cell apoptosis in mice. Genomics 72:73-77. tron RBE for induction of tumors with high lethality in Sprague-Dawley Weinberg, H.S., A.B. Korol, V.M. Kirzhner, T. Fahima, E. Nevo, S. rats. Radiat Res 154:412-420. Shapiro, G. Rennert, O. Piatak, E.I. Stepanova, and E. Skvarskaja. 2001. Wolff, S. 1989. Are radiation-induced effects hormetic? Science 245: Very high mutation rate in offspring of Chernobyl accident liquidators. 575, 621. Proc R Soc Lond 268:1001-1005. Wolff, S. 1992a. Low dose exposures and the induction of adaptation. Pp. Weinberg, R.A. 1994. Oncogenes and tumor suppressor genes. CA-Cancer 21-28 in Low Dose Irradiation and Biological Defense Mechanisms, T. J Clin 44:160-170. Sugahara and others, eds. Amsterdam, London, New York, Tokyo: Weiss, H.A., S.C. Darby, and R. Doll. 1994. Cancer mortality following x- Excerpta Medica. ray treatment for ankylosing spondylitis. Int J Cancer 59:327-338. Wolff, S. 1992b. Failla Memorial Lecture. Is radiation all bad? The search Weiss, H.A., S.C. Darby, T. Fearn, and R. Doll. 1995. Leukemia mortality for adaptation. Radiat Res 131:117-123. after x-ray treatment for ankylosing spondylitis. Radiat Res 142:1-11. Wolff, S. 1996. Aspects of the adaptive response to very low doses of radia- White, E., and C. Prives. 1999. DNA damage enables p73. Nature 399:734- tion and other agents. Mutat Res 358:135-142. 735, 737. Wong, F.L., M. Yamada, H. Sasaki, K. Kodama, S. Akiba, K. Shimaoka, White, E., S.K. Chiou, L. Rao, P. Sabbatini, and H.J. Lin. 1994. Control of and Y. Hosoda. 1993. Noncancer disease incidence in the atomic bomb p53-dependent apoptosis by E1B, Bcl-2, and Ha-ras proteins. Cold survivors: 1958-1986. Radiat Res 135:418-430. Spring Harb Symp 59:395-402. Wong, F.L., J.D. Boice Jr., D.H. Abramson, R.E. Tarone, R.A. Kleinerman, Whitehouse, C.A., and E.J. Tawn. 2001. No evidence for chromosomal M. Stovall, M.B. Goldman, J.M. Seddon, N. Tarbell, J.F. Fraumeni Jr., instability in radiation workers with in vivo exposure to plutonium. and F.P. Li. 1997a. Cancer incidence after retinoblastoma. Radiation Radiat Res 156:467-475. dose and sarcoma risk. J Am Med Assoc 278:1262-1267. Whitehouse, C.J., R.M. Taylor, A. Thistlethwaite, H. Zhang, F. Karimi- Wong, F.L., J.D. Boice Jr., D.H. Abramson, R.E. Tarone, R.A. Kleinerman, Busheri, D.D. Lasko, M. Weinfeld, and K.W. Caldecott. 2001. XRCC1 M. Stovall, M.B. Goldman, J.M. Seddon, N. Tarbell, J.F. Fraumeni Jr., stimulates human polynucleotide kinase activity at damaged DNA ter- and F.P. Li. 1997b. Cancer incidence after retinoblastoma. Radiation mini and accelerates DNA single-strand break repair. Cell 104:107-117. dose and sarcoma risk. J Am Med Assoc 278:1262-1267. Whittemore, A. S.1978. Quantitative theories of oncogenesis. Adv Cancer Wong, F.L., M. Yamada, H. Sasaki, K. Kodama, and Y. Hosoda. 1999. Res, v. 27: 55-88. Effects of radiation on the longitudinal trends of total serum cholesterol WHO (World Health Organization). 1998. The public health impact of levels in atomic bomb survivors. Radiat Res 151:736-746. nuclear weapons testing in Kazakhstan. World Health Organization Wood, R.D., M. Mitchell, J. Sgouros, and T. Lindahl. 2001. Human DNA Report. repair genes. Science 291:1284-1289. Wiggs, L.D., C.A. Cox-DeVore, and G.L. Voelz. 1991a. Mortality among a Worgul, B.V., L. Smilenov, D.J. Brenner, A. Junk, W. Zhou, and E.J. Hall. cohort of workers monitored for 210Po exposure: 1944-1972. Health 2002. ATM heterozygous mice are more sensitive to radiation-induced Phys 61:71-76. cataracts than are their wild-type counterparts. Proc Natl Acad Sci USA Wiggs, L.D., C.A. Cox-DeVore, G.S. Wilkinson, and M. Reyes. 1991b. 99:9836-9839. Mortality among workers exposed to external ionizing radiation at a Wouters, B.G., A.M. Sy, and L.D. Skarsgard. 1996. Low-dose hypersensi- nuclear facility in Ohio. J Occup Med 33:632-637. tivity and increased radioresistance in a panel of human tumor cell lines Wiggs, L.D., E. Johnson, C. Cox-Devore, and G. Voelz. 1994. Mortality with different radiosensitivity. Radiat Res 146:399-413. through 1990 among white male workers at the Los Alamos National Wright, E.G. 2000. Genomic instability manifestations and mechanisms. Laboratory: considering exposures to plutonium and external ionizing Pp. 483-487 in Radiation Research 2, M. Moriarty and others, eds. radiation. Health Phys 67:577-588. Lawrence: Allen Press. Wilkinson, G.S., G.L. Tietjen, L.D. Wiggs, W.A. Galke, J.F. Acquavella, Wu, H.I., J.A. Brown, M.J. Dorie, L. Lazzeroni, J.M. Brown. 2004. Ge- M. Reyes, G.L. Voelz, and R.J. Waxweiler. 1987. Mortality among plu- nome-wide identification of genes conferring resistance to the antican- tonium and other radiation workers at a plutonium weapons facility. cer agents cisplatin, oxaliplatin, and mitomycin C. Cancer Res 64:3940- Am J Epidemiol 125:231-250. 3948. Williams, E.D. 1997. Thyroid Cancer and the Chernobyl Accident. Health Wu, L.J., G. Randers-Pehrson, A. Xu, C.A. Waldren, C.R. Geard, Z. Yu, Effects of Low Dose Radiation. London: British Nuclear Energy Soci- and T.K. Hei. 1999. Targeted cytoplasmic irradiation with alpha par- ety. ticles induces mutations in mammalian cells. Proc Natl Acad Sci USA Williams, E.D. 2003. Chernobyl, 15 years later, correlation of clinical, epi- 96:4959-4964. demiological and molecular outcomes. Ann Endocrinol 64:72. Wu, X., J. Li, X. Li, C.L. Hsieh, P.M. Burgers, and M.R. Lieber. 1996. Wilson, D.M., 3rd, and L.H. Thompson. 1997. Life without DNA repair. Processing of branched DNA intermediates by a complex of human Proc Natl Acad Sci USA 94:12754-12757. FEN-1 and PCNA. Nucleic Acids Res 24:2036-2043. Wing, S., C. Shy, J. Wood, S. Wolf, D. Cragle, and E. Frome. 1991. Mortal- Wyllie, A. 1998. Apoptosis. An endonuclease at last. Nature 391:20-21. ity among workers at Oak Ridge National Laboratory. Evidence of ra- Xanthoudakis, S., R.J. Smeyne, J.D. Wallace, and T. Curran. 1996. The diation effects in follow-up through 1984. J Am Med Assoc 265:1397- redox/DNA repair protein, Ref-1, is essential for early embryonic de- 1402. velopment in mice. Proc Natl Acad Sci USA 93:8919-8923. Wing, S., C. Shy, J. Wood, S. Wolf, D. Cragle, W. Tankersley, and E. Xia, F., X. Wang, Y.H. Wang, N.M. Tsang, D.W. Yandell, K.T. Kelsey, Frome. 1993. Job factors, radiation and cancer mortality at Oak Ridge and H.L. Liber. 1995. Altered p53 status correlates with differences in National Laboratory: follow-up through 1984. Am J Ind Med 23:265- sensitivity to radiation-induced mutation and apoptosis in two closely 279. related human lymphoblast lines. Cancer Res 55:12-15. Witt, K.L., and J.B. Bishop. 1996. Mutagenicity of anticancer drugs in mammalian germ cells. Mutat Res 355:209-234.

OCR for page 337
372 REFERENCES Xu, Y., T. Ashley, E.E. Brainerd, R.T. Bronson, M.S. Meyn, and D. Balti- Yuhas, J.M. 1974. Recovery from radiation-carcinogenic injury to the more. 1996. Targeted disruption of ATM leads to growth retardation, mouse ovary. Radiat Res 60:321-332. chromosomal fragmentation during meiosis, immune defects, and thy- Zablotska, L.B., J.P. Ashmore, and G.R. Howe. 2004. Analysis of mortality mic lymphoma. Genes Dev 10:2411-2422. experience amongst Canadian nuclear power industry workers follow- Yang, C.R., K. Leskov, K. Hosley-Eberlein, T. Criswell, J.J. Pink, T.J. ing chronic low-dose exposure to ionizing radiation. Radiat Res Kinsella, and D.A. Boothman. 2000. Nuclear clusterin/XIP8, an x-ray- 161:633-641. induced Ku70-binding protein that signals cell death. Proc Natl Acad Zaridze, D.G., N. Li, T. Men, and S.W. Duffy. 1994. Childhood cancer Sci USA 97:5907-5912. incidence in relation to distance from the former nuclear testing site in Yang, N., H. Galick, and S.S. Wallace. 2004. Attempted base excision re- Semipalatinsk, Kazakhstan. Int J Cancer 59:471-475. pair of ionizing radiation damage in human lymphoblastoid cells pro- Zhang, S., E.S. Ramsay, and B.A. Mock. 1998. Cdkn2a, the cyclin-depen- duces lethal and mutagenic double strand breaks. DNA Repair 3:1323- dent kinase inhibitor encoding p16INK4a and p19ARF, is a candidate 1334. for the plasmacytoma susceptibility locus, Pctr1. Proc Natl Acad Sci Yauk, C.L., Y.E. Dubrova, G.R. Grant, and A.J. Jeffreys. 2002. A novel USA 95:2429-2434. single molecule analysis of spontaneous and radiation-induced muta- Zhao, S., Y.C. Weng, S.S. Yuan, Y.T. Lin, H.C. Hsu, S.C. Lin, E. Gerbino, tion at a mouse tandem repeat locus. Mutat Res 500:147-156. M.H. Song, M.Z. Zdzienicka, R.A. Gatti, J.W. Shay, Y. Ziv, Y. Shiloh, Yin, E., D.O. Nelson, M.A. Coleman, L.E. Peterson, and A.J. Wyrobek. and E.Y. Lee. 2000. Functional link between ataxia-telangiectasia and 2003. Gene expression changes in mouse brain after exposure to low- Nijmegen breakage syndrome gene products. Nature 405:473-477. dose ionizing radiation. Int J Radiat Biol 79:759-775. Zheng, N., D.G. Monckton, G. Wilson, F. Hagemeister, R. Chakraborty, Yokoro, K., M. Nakano, A. Ito, K. Nagao, and Y. Kodama. 1977. Role of T.H. Connor, M.J. Siciliano, and M.L. Meistrich. 2000. Frequency of prolactin in rat mammary carcinogenesis: detection of carcinogenicity minisatellite repeat number changes at the MS205 locus in human sperm of low-dose carcinogens and of persisting dormant cancer cells. J Natl before and after cancer chemotherapy. Environ Mol Mutagen 36:134- Cancer Inst 58:1777-1783. 145. Yoshimoto, Y., H. Kato, and W.J. Schull. 1988. Risk of cancer among chil- Zhou, P.K., and O. Rigaud. 2001. Down-regulation of the human CDC16 dren exposed in utero to A-bomb radiations, 1950-84. Lancet 2:665- gene after exposure to ionizing radiation: a possible role in the 669. radioadaptive response. Radiat Res 155:43-49. Yoshinaga, S., T. Aoyama, Y. Yoshimoto, and T. Sugahara. 1999. Cancer Zhou, P.K., X.Y. Liu, W.Z. Sun, Y.P. Zhang, and K. Wei. 1993. Cultured mortality among radiological technologists in Japan: updated analysis mouse SR-1 cells exposed to low doses of gamma-rays become less of follow-up data from 1969 to 1993. J Epidemiol 9:61-72. susceptible to the induction of mutagenesis by radiation as well as Young, H.E. 2004. Existence of reserve quiescent stem cells in adults, from bleomycin. Mutagenesis 8:109-111. amphibians to humans. Curr Top Microbiol 280:71-109. Zhou, H., G. Randers-Pehrson, C.A. Waldren, D. Vannais, E.J. Hall, and Youngblom, J.H., J.K. Wiencke, and S. Wolff. 1989. Inhibition of the adap- T.K. Hei. 2000. Induction of a bystander mutagenic effect of alpha par- tive response of human lymphocytes to very low doses of ionizing ra- ticles in mammalian cells. Proc Natl Acad Sci USA 97:2099-2104. diation by the protein synthesis inhibitor cycloheximide. Mutat Res Zielinski, J., R. Kodell, and D. Krewski. 2001. Interaction between two 227:257-261. carcinogens in the two-stage clonal expansion model of carcinogenesis. Yu, Y., C.Y. Li, and J.B. Little. 1997. Abrogation of p53 function by HPV16 J Epidemiol Biostat 6:219-228. E6 gene delays apoptosis and enhances mutagenesis but does not alter radiosensitivity in TK6 human lymphoblast cells. Oncogene 14:1661- 1667. Yu, Y., R. Okayasu, M.M. Weil, A. Silver, M. McCarthy, R. Zabriskie, S. Long, R. Cox, and R.L. Ullrich. 2001. Elevated breast cancer risk in irradiated BALB/c mice associates with unique functional polymor- phism of the Prkdc (DNA-dependent protein kinase catalytic subunit) gene. Cancer Res 61:1820-1824.